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Gap junctional channels are present at cell-cell contact area. 
Cell communication through gap junctions (GJs) regulates basic 
processes such as cell growth and differentiation, and maintains 
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homeostasis. Gap junction intercellular communication (GJIC) 
reflects the flux of small (< 1 kDa) and hydrophilic molecules, 
such as glucose, glutamate, and adenosine trisphosphate (ATP), 
as well as ions, through these channels via passive diffusion. 
Six connexins cluster into a connexon, and two connexons dock 
together to form a gap junction channel. Gap junctions cluster 
together to form plaques and the gap junction complex is made 
up of connexins. Individual Cxs are defined and named based on 
their molecular weight and differ in both function and 
expression pattern. Abnormality of GJIC is associated with 
numerous diseases, specifically, the downregulation and 
dysfunction of GJIC are typical features of various cancers and 
diseases.  
To explore the role of Cx32 in gastric carcinogenesis, we 
investigated altered expression and localization of Cx32 protein 
in human gastric cancer, using a tissue array-based approach 
and Helicobacter pylori-induced murine gastric tumors and 
preneoplastic changes (mucous metaplasia). We examined the 
relationship between expression of Cx32 and cell proliferation 
marker Ki67 or cell-cycle regulatory proteins p21Cip1 or p27Kip1 
using immunohistochemistry. Also, the relationship between 
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expression of Cx32 and that of adhesion protein was 
investigated. In addition, we examined cell proliferation, cell 
cycle distribution, and levels of the cell-cycle regulatory 
proteins p21Cip1 and p27Kip1 after Cx32 overexpression in the 
human gastric cancer cell line AGS.  
In immunohistochemical analyses, the frequency of Cx32 loss 
of expression was significantly higher in human 
adenocarcinomas than in normal stomach. As tumor cells were 
less differentiated, Cx32 expression levels and intercellular and 
intracytoplasmic staining were also significantly lower. Cx32 
expression in foveolar surface cells in the gastric pit was 
strong, whereas that in basal cells was weak. Deep pyloric 
glandular cells showed punctuate Cx32 staining in the 
membranes and/or cytoplasm. In tumor cells this intercellular 
expression was lost, and Cx32 expression varied according to 
the differentiation status of tumor cells. Some adenocarcinomas 
showed mild to moderate Cx32 expression in the cytoplasm as 
intracytoplasmic dots whereas others showed loss of staining. 
In mucous metaplasia of the mouse stomach, Cx32 was mainly 
expressed in the cytoplasm of epithelial cells. An examination 
of Ki67-positivity in relation to the pattern of Cx32 expression 
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in human and murine gastric tissue showed that the frequency 
of Ki67-positive cells was increased as Cx32 localization 
shifted from a membranous to cytoplasmic pattern, and was 
further increased with loss of expression. We then investigated 
the correlation between expression of the typical cell-cycle 
regulatory proteins p21Cip1 or p27Kip1 and that of Cx32. As the 
Cx32 expression changed from normal membranous expression 
to cytoplasmic expression or was lost, the p21Cip1- and 
p27Kip1-positive cell rate decreased (negative staining). The 
relationship between Cx32 expression and E-cadherin or β-
catenin expression showed significant correlations using 
immunohistochemistry. As Cx32 expression was turning from 
normal membranous expression to cytoplasmic expression and 
was eventually lost, the E-cadherin and β-catenin expression 
also changed from the normal membranous expression to 
cytoplasmic expression and was eventually lost or showed 
nuclear expression, respectively. To further examine the direct 
relationship between Cx32 expression and cell proliferation, 
AGS cells were transfected with a Cx32 expression plasmid or 
control vector. Cell proliferation was decreased in AGS cells 
overexpressing Cx32 compared to AGS cells wild-type or AGS 
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cells transfected with control vector. The percentage of G1-
phase cells was significantly greater and that of S-phase was 
less in AGS cells overexpressing Cx32 vector than in AGS cells 
wild-type or AGS cells transfected with control vector. Real-
time reverse transcription polymerase chain reaction (RT-
PCR) and Western blot analyses revealed p21Cip1 and p27Kip1 
levels were greater in AGS cells overexpressing Cx32 vector 
compared to control groups. 
In conclusion, our immunohistochemical analysis 
demonstrated that the altered Cx32 expression, specifically the 
loss of Cx32 expression and the gain of intracytoplasmic Cx32, 
was observed not only in adenocarcinoma and adenoma but also 
in mucous metaplasia. And we found a correlation between 
Cx32 expression pattern and cell proliferation. Our in vitro 
study of the effects of Cx32 overexpression showed that Cx32 
inhibited the proliferation of gastric cancer cells through cell 
cycle arrest and upregulation of p21Cip1 and p27Kip1. Together, 
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Gap junctions (GJs) are classically defined as clusters of a few 
to hundreds of tightly packed intercellular channels that 
function, in the simplest assessment, to allow small the 
exchanges of molecules between adjoining cells (Alexander and 
Goldberg 2003). This exchange forms a critical system for 
intercellular communication in cell and tissue biology and GJs 
are found in nearly every mammalian cell type (Goodenough, 
Goliger and Paul 1996, Saez et al. 2003). In vertebrates, GJs 
are formed largely by the connexin (Cx) family of proteins. The 
Cxs oligomerize to form a hexameric hemichannel termed a 
connexon, and two connexons dock in opposing membranes to 
form the GJ channel (Text figure 1) (Kumar and Gilula 1996, 
Wei, Xu and Lo 2004). In mammals, Cxs are encoded by at least 
20 different genes, which exhibit tissue and cell-type 
specificity, but also show overlapping patterns of expression 
(Goodenough et al. 1996, Willecke et al. 2002, Laird 2006). All 
Cx subtypes share a common structure, consisting of four 
trans-membrane domains with two extracellular loops, an 
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intracellular loop, and the cytoplasmic C- and N-termini. 
Identical or different Cxs can oligomerize to form homomeric or 
heteromeric connexons, respectively. The channels assembled 
from Cx family members serve a common purpose of allowing 
the intercellular exchange of small metabolites, second 
messengers and electrical signals, but the diversity of function 
of channels is attributed to a subset of Cxs that are expressed 
in specific cell types (White 2003). Not all channels are the 
same, although they share the property of excluding molecules 
that exceed 1 kDa in size (Bennett and Verselis 1992, Moreno 
2004, Bukauskas and Verselis 2004). Importantly, small 
molecules that differ in size, shape, and charge can be included 
or excluded from passage through distinctly different GJ 
channel subtypes, which result in a wide variety of 
transjunctional selectivity for specific molecules (Bukauskas 
and Verselis 2004, Goldberg et al. 1998, Goldberg, Lampe and 
Nicholson 1999). Collectively, secondary messengers and small 
metabolites are recognized as be the molecular constituents 
that directly pass from one cell to another through these 
channels. Important transjunctional molecules include cyclic 
adenosine mono-phosphates (cAMP), inositol triphosphate, 
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adenosine, adenosine di-phosphate (ADP), and adenosine tri-
phosphate (ATP), to name only a few (Goldberg, Valiunas and 
Brink 2004, Goldberg et al. 1998, Goldberg et al. 1999). The 
intermixing of Cx subunits within the same channel becomes 
even more important as we attempt to understand the 
mechanisms associated with diseases linked to autosomal 
recessive and dominant mutations of Cxs. 
Given the large number of Cxs, it is not surprising to learn 
that their cellular and tissue distribution is overlapping, yet 
distinct. Three fundamental principles come to the forefront: 
First, many tissues and cell types express two or more 
members of the Cx family. For example, keratinocytes express 
at least Cx26, Cx30, Cx30.3, Cx31, Cx31.1, and Cx43 
(Salomon et al. 1994, Wiszniewski et al. 2000, Kretz et al. 
2003, Goliger and Paul 1994, Di et al. 2005). Likewise, 
cardiomyocytes express Cx40, Cx43, and Cx45 (Moreno 2004, 
Beyer et al. 1995, Gros and Jongsma 1996) and hepatocytes 
express Cx26 and Cx32 (Paul 1986, Zhang and Nicholson 
1989, Hennemann et al. 1992, Zhang and Nicholson 1994, 
Laird 2006). Collectively, co-expression of multiple Cx family 
members within the same cell type allows for possible 
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compensatory mechanisms to overcome the loss or mutation of 
one Cx family member (Hombach et al. 2004, Kelsell et al. 
1997). However, a second principle to note from the Cx 
distribution patterns is that even though two or more Cxs may 
be co-expressed in the same cell, the resulting channels that 
form cannot always compensate for the loss or mutation of a 
Cx family member (Richard et al. 2002, Richard et al. 2004, 
White 2003, Laird 2006). The third notable observation, from 
the examination of Cx expression patterns in mammals, is that 
the most ubiquitously expressed Cx is Cx43. The Cx43 is now 
known to be endogenously expressed in at least 35 distinct 
tissues encompassing over 35 cell types, including 
cardiomyocytes, keratinocytes, astrocytes, and smooth-
muscle cells, among many others (Richard et al. 2002, Dahl et 
al. 1995, Saitoh et al. 1997, Darrow et al. 1995, Kamibayashi 







Text figure 1. From connexin (Cx) to gap junction complex.  
Six Cxs (Cx is represented as a cylinder) cluster into a 
connexon, and two connexons dock together to form a gap 
junction channel. Many gap junctions cluster together to form 
plaques. The gap junction complex made up of Cxs and their 
associated proteins is shown. (Source: Kidney international 





Life Cycle of Connexins  
Remarkably, Cx proteins have a short half-life of only a few 
hours. This short lifespan has been well documented (Laird, 
Puranam and Revel 1991, Fallon and Goodenough 1981), and 
confirms that Cxs are pre-programmed for continuous 
biosynthesis and degradation. Some physiological changes may 
not demand dramatic changes in GJ status. However, the 
general ability of cells to govern their overall level of GJIC 
through alteration of expression levels, coupled to assembly 
and degradation events allows for an exquisite level of 
regulation that extends beyond the rapid channel opening and 
closing events associated with channel gating (Bukauskas and 
Verselis 2004, Harris 2001).  
Similar to other classical integral membrane proteins, Cxs are 
thought to co-translationally thread into the endoplasmic 
reticulum (ER) via the translocon and encoded start and stop 
transfer sequences (Falk and Gilula 1998, Laird 2006). The Cx 
oligomerization then occurs during the residence time within the 
ER (Ahmad et al. 1999, Falk and Gilula 1998) (Text figure 2). 
Upon exiting the ER, properly folded Cxs are passed through 
the ER-Golgi intermediate compartment (ERGIC) prior to 
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entering the cis-Golgi network. For at least some members of 
the Cx family, complete oligomerization is delayed until the Cx 
passes through the intermediate compartment and reaches the 
distal elements of the Golgi apparatus, namely the trans-Golgi 
network (TGN) (Musil and Goodenough 1993, Koval et al. 1997, 
Laird 2006, Lauf et al. 2002). Cx26 is an exception to this rule, 
as it can reach the cell surface via a Golgi-independent 
pathway (Martin, Errington and Evans 2001, Evans et al. 1999). 
Pleomorphic vesicles and transport intermediates are thought to 
deliver closed connexons to the cell surface, a process that is 
facilitated by microtubules (Lauf et al. 2002, Thomas et al. 
2005, Jordan et al. 1999). Connexons may function as 
hemichannels and exchange small molecules with the 
extracellular environment. Alternatively, they may diffuse 
laterally in a closed state to sites of cell-cell apposition and 
dock with connexons from an opposing cell, under the guidance 
of specific N- and E-cadherin-based adhesion events (Laird 
2006, Wei et al. 2005). Recent studies have suggested that N-
cadherin and Cx43 in fact may co-assemble, which suggests 
the occurrence of direct cross-talk between adherens junctions 
and GJs (Wei et al. 2005). In conjunction with cadherin-based 
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cell adhesion, GJ channels cluster into plaques and then open 
and exchange secondary messengers. New GJ channels are 
recruited to the margins of GJ plaques, while older channels are 
found in the center of the plaques (Laird 2006, Gaietta et al. 
2002). One interpretation of these findings is that the older 
channels in the middle of a plaque are destined for 
internalization and degradation. Several Cx-binding proteins 
have been identified, and one or more of these binding proteins 
likely regulates plaque formation and stability, possibly by 
acting as a scaffold for cytoskeletal elements. GJ plaques and 
fragments of GJ plaques are internalized into one of two 
adjacent cells as a double-membrane structure commonly 
referred to as an annular junction. These structures represent 
the products of one cell internalizing either the entire GJ or a 
fragment of it (Severs et al. 1989, Sasaki and Garant 1986). 
Since the term ‘annular junction’ is descriptive in nature and 
does not implicitly refer to these structures originating from 
GJs, these structures have been renamed connexosomes (Laird 
2006). This new nomenclature was validated by a study that 
used fluorescent-tagged Cxs. Anti-Cx43 antibody 
microinjection studies, together with live imaging of green 
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fluorescence protein (GFP)-tagged Cx43, revealed that the 
origin of annular junctions was in fact from pre-existing GJ 
plaques at cell-cell interfaces (Jordan et al. 2001). Other 
pathways for Cx internalization may exist, where connexons 
disassemble and enter the cell by classical endocytic pathways 
(Fujimoto et al. 1997). Proteasomes are involved either directly 
or indirectly in regulation of Cx degradation (Laing and Beyer 
1995, Leithe and Rivedal 2004a, Leithe and Rivedal 2004b), as 
compelling evidence has been reported for a delay in the 
degradation of Cx43 in the presence of proteasome inhibitors 
(Laing and Beyer 1995). However, other drug-based studies 
convincingly argue for degradation of Cxs in lysosomes (Leithe 
and Rivedal 2004a, Leithe and Rivedal 2004b, Laird 2006). This 
apparent discrepancy may be resolved by the observation that a 
subpopulation of Cx43 and Cx32 can apparently be reverse-
translocated from the ER into the cytosol in proteasomal-
inhibitor-treated cells, a process that is inhibited by cytosolic 
stress (VanSlyke and Musil 2002). Consequently, a scenario 
can be envisioned whereby proteasomes are responsible for 
ER-associated-degradation (ERAD), whereas lysosomes only 









Text figure 2. Life cycle of a connexin.  
Connexins are typically co-translationally inserted into the 
endoplasmic reticulum (ER). If properly folded, Cxs are in all 
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likelihood spared from ER-associated-degradation (ERAD), 
whereas in other cases they may be targeted for ERAD. Cxs 
pass through the Golgi apparatus. On exiting the trans-Golgi 
network (TGN), Cxs enter a variety of transport intermediates 
of different sizes and shapes that are used for delivery of the 
Cx cargo to the cell surface. Cx transport is mediated in part by 
microtubules. Once inserted into the plasma membranes, 
connexons freely diffuse within the lipid bilayer and dock with 
connexons from adjacent cells to form gap-junction (GJ) 
channels. The clustering of individual GJ channels appears to be 
a continually active and dynamic process. GJs formed from the 
outer margins of the plaques, while older channels become 
localized at the center of the plaques. After old and new 
channels are distinctly separated within the GJ plaque, double-
membrane vesicular structures termed ‘annular junctions’ 
can be identified; these are now referred connexosomes. 
Internalized GJs are targeted for degradation in lysosomes, 
although some evidence suggests a role for proteasomal 
degradation. (Source: Biochem J 2006 394, 527-543) 
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Connexins and Cancer 
The hypothesis, that GJIC is involved in cancer and more 
generally in the control of growth in an old and recurrent story. 
This assumption is almost as old as the first description of GJs 
in the 1960s, and was described much before the molecular 
structure of GJs was known. The hypothesis was first proposed 
by W. Loewenstein and his colleagues, who reported that the 
cancer cells they were studying did not communicate through 
GJs. What they observed was an apparent lack of ionic coupling 
between hepatoma cells derived from chemically induced liver 
tumors of rats or between transplanted human hepatoma cells 
(Loewenstein and Kanno, 1966, 1967). This lack of cell 
coupling was also observed in thyroid tumors in rodents and in 
carcinoma of the stomach in humans (Jamakosmanovic and 
Loewenstein, 1968, Kanno and Mitsui, 1968). The molecules 
expected to pass through GJs could also inhibit the proliferation 
of cells transformed by the polyoma virus (Stoker, 1964). All of 
these observations were supported a general hypothesis for a 
lack of GJs in cancers. 
In fact, loss of Cxs and GJIC is common marker of malignancy. 
Cx43, the best-known Cx, shows diminished expression in 
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human tumors when compared with adjacent normal tissues, 
such as breast and prostate (Laird et al. 1999, Tsai et al. 1996). 
The general observation is that Cxs and GJIC are lost in cancer 
cells, which suggests that GJICs play a tumor-suppressing role 
(Mesnil et al. 2005). Multiple tumor-promoting agents, such as 
12-O-tetradecanoylphorbol- 13-acetate (TPA) or cigarette 
components, and oncogenes such as Ras and Src, have long 
been known to regulate Cx expression and phosphorylation and 
to inhibit GJIC (Brissette et al. 1991, Leithe and Rivedal 2004a, 
Tai et al. 2007, Peterson-Roth, Brdlik and Glazer 2009). In 
contrast, restoration of GJIC and Cx43 in cancer cells has been 
shown to inhibit their growth (Fernstrom et al. 2002, Zhang et 
al. 2001, Xu et al. 2008). Extensive studies have reported that 
a loss, or at least a diminution, of coupling capacity is common 
between cancer cells and their surrounding normal counterparts 
(Text figure 3). 
In addition to their potential role in tumorigenesis, Cxs are 
also thought to be involved in tumor metastasis, although the 
data are equivocal. The metastatic process involves multiple 
steps that include cell migration, invasion, angiogenesis, 
intravasation, and extravasation. Emerging evidence suggests 
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that GJIC and Cxs contribute to cell adhesion, migration, and 
metastasis of breast cancer. Overexpression of Cx43 is also 
indicated to affect angiogenesis in both in vitro and in vivo 
studies, through regulation of various angiogenesis-linked 
proteins such as the Monocyte chemotactic protein-1 (MCP-
1) and interleukin-6(IL-6), which inhibit in vitro endothelial 
cell tubulogenesis and migration (McLachlan et al. 2006). 
Metastatic homing of cancer cells to the lung appears to be 
facilitated by GJIC through Cx43 expression and increased 
adhesion to endothelial cells (Elzarrad et al. 2008). 
Paradoxically, Cxs have been suggested to contribute to 
metastasis of breast cancer to the lymph nodes. Expression of 
Cx26 and Cx43 was increased in metastases to lymph nodes 
(MLNs) when compared with matched primary breast tumors 
(PTs), while Cx26- and Cx43-negative PTs developed Cx26- 
and Cx43-positive MLNs (Kanczuga-Koda et al. 2006). Bone 
marrow studies provide additional evidence that Cxs and GJIC 
may play different and context-dependent roles in metastasis. 
Upon entry into the marrow, breast cancer cells reach the 
endosteum to form Cx43 GJs with bone marrow stroma cells, an 
event that is partly mediated by the Tac1 gene, a potential 
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metastatic marker (Moharita et al. 2006).  
In summary, Cxs appear to have a dynamic role in the 
metastatic process, involving multiple factors. A specific series 
of events leads to metastasis: tumor cells leave the PT, travel 
to distant sites, and some establish as secondary tumors. One 
might surmise that the detachment of tumor cells would 
necessitate the loss of intercellular junctions. In contrast, the 
other stages or steps in the metastatic process, such as 
intravasation, endothelial attachment, and vascularization, might 
be enhanced by or even require increased cell-cell contact. 
This diversity in roles of Cxs and GJIC in tumor progression 





Text figure 3. Possible mechanisms leading to an inhibition of 
gap-junctional intercellular communication (GJIC) capacity in 
cancer.  
Various experimental data have shown that each step leading to 
the establishment of GJIC can be altered, thereby inducing the 
loss of junctional communication. Four major events (STOPS) 
appear to be the cause of a lack of junctional communication 
(lack of transcription of connexin (Cx) genes; lack of 
translation of connexin mRNA; lack of membrane addressing 
leading to an accumulation of Cx proteins in the cytoplasm; and 
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lack of cell–cell recognition preventing the establishment of 
junctional intercellular communication). Recent data indicate 
that the reestablishment of GJIC by connexin cDNAs may be 
not sufficient for inducing cell growth control in cancer cells 
(STOP 5). In this last case, the expression of specific Cxs 
seems to be a more critical event than the recovery of 
junctional communication. In other words, Cxs could control cell 
growth in a manner that is independent of cell-cell 




Connexins and Aberrant Localization 
Some cancers are also characterized by an aberrant localization 
of Cx proteins (Mesnil et al. 2005, Nakashima et al. 2004). 
Since GJs are composed exclusively of Cx protein, aberrant 
localization of Cx protein should logically lead to downregulation 
of GJIC in the form of ‘loss of function’. However, a few 
reports have presented immunohistochemical evidence showing 
that tumors with higher-grade malignancy tend to exhibit a 
more intense staining of Cx protein in cytoplasm (Krutovskikh 
et al. 1994, Mehta et al. 1999). In contrast, metastasized 
tumors, despite the lack of Cx expression in the primary tumor, 
show restored expression of a certain Cx proteins, but these 
are localized within the cytoplasm rather than on the plasma 
membrane (Kanczuga-Koda et al. 2006). Krutovskikh et al. 
examined 20 surgical samples of human hepatocellular 
carcinoma (HCC) for the expression pattern of Cx32 protein 
and found that stronger signals of Cx32 protein were found in 
the cytoplasm of poorly differentiated HCC than in well 
differentiated HCC (Krutovskikh et al. 1994). Mehta et al. 
immunostained 20 primary and 20 metastatic lesions of human 
prostate cancer, along with normal counterparts, to detect Cx32 
20 
 
and Cx43 proteins (Mehta et al. 1999). While both Cx43 and 
Cx32 gave punctate signals in cell-cell contact areas of acinar 
epithelial cells in both normal tissues and well differentiated 
adenocarcinoma tissues, both Cx proteins were localized in the 
cytoplasm in poorly-differentiated and undifferentiated 
carcinoma tissues and no GJ plaques were formed. More 
interestingly, Kanczuga-Koda et al. clearly showed that both 
Cx26 and Cx43 proteins were expressed much more frequently 
in the cytoplasm in tumors that had metastasized to lymph 
nodes when compared to the primary lesions of human breast 
cancers (Kanczuga-Koda et al. 2006). More recently, 
experimental data have shown that altered Cx32 expression 
specifically the loss of intercellular Cx32 and the gain of 
intracytoplasmic Cx32 plays an important role in gastric 
carcinogenesis (Jee et al. 2011).  
The overexpression of Cx32 protein in the cytoplasm of 
human hepatoma cells enhances cell motility and invasiveness 
and ultimately induces in vivo metastasis without forming GJs 
(Li et al. 2007). The effects of cytoplasmic localization of Cx32 
protein on tumor progression of HCC were assessed by 
retroviral transduction of human HuH7 HCC cells with the Tet-
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off Cx32 construct, which directed overexpression of the Cx32 
protein within the cytoplasm. Subcellular fractionation 
confirmed that no Cx32 protein was present in the cell surface 
protein fraction of the transformed cells. Interestingly, the 
population doubling time of the HuH7 Tet-off Cx32 cells was 
significantly shorter than mock-transformed HuH7 Tet-off 
cells. To verify whether overexpression of the cytoplasmic 
Cx32 protein enhanced the in vivo metastatic capability, the 
cells were xenografted into a subserosal area of the liver of 
SCID mice. Overexpression of cytoplasmic Cx32 protein 
induced metastases of the intrahepatic xenografts without 
enhancing their tumorigenicity (Li et al. 2007).  
Taken together, these results suggest that translocation of 
Cx protein from the plasma membranes to the cytoplasm could 
lead not only to downregulation of GJIC but could also promote 




Connexins and Cell Proliferation 
A link between GJs and cell growth has also been established. 
This has been confirmed by investigations ranging from 
inhibition of GJIC by carcinogens to decreasing growth by 
reinduction of GJIC through Cx cDNA transfection or chemical 
treatment. Overexpression of Cx43 decreased the proliferation 
of human lung cancer-derived cells (Xu et al. 2008). 
Transgenic mice also exhibited higher tumor susceptibility 
when defective for specific Cxs: Cx32-deficient mice tended to 
develop liver tumors, while lung neoplasia was prevalent in 
Cx43-deficient mice (Temme et al. 1997, Avanzo et al. 2004).  
Any change in cell proliferation is expected to show a related 
change in cell-cycle gene expression. Consequently, other 
similar strategies revealed that transfection of Cx could 
influence expression of genes involved in cell cycle regulation. 
Interestingly, the proliferation of transfected cells was 
associated with a decreased expression of cell cycle regulatory 
genes, such as cyclin A, D1, D2, and cyclin-dependent kinases 
(CDK) 5 and CDK6. These genes are now established as 
critical for cell cycle progression, which could explain the 
increased duration of the G1- and S-phases observed in the 
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transfected cells (Chen et al. 1995). A longer G1 phase was 
also observed following Cx43 transfection in osteosarcoma 
cells, probably due to reduced degradation of p27Kip1, an 
inhibitor of CDK activity. Inhibition of CDK, results in 
accumulation of the hypophosphorylated form of Rb, a 
characteristic of the G1 phase (Zhang et al. 2001). A similar 
effect has been observed after Cx transfection of liver (Cx32) 
and lung (Cx43) carcinoma cells, where a prolongation of the 
G1-phase was linked to p27 Kip1 accumulation and to a 
decreased amount of cyclin D1 (Koffler et al. 2000). An 
increased amount of p27 Kip1 and a decrease of Skp2 (S-phase 
kinase–associated protein-2) were also reported following 
Cx43 expression (Zhang et al. 2001, Zhang, Nakayama and 
Morita 2003). The real impact of connexins in cell-growth 
regulation is not yet understood, even if some molecular 





Text figure 4. Connexins and cell-growth regulation.  
In this cell, molecular events associating connexins and 
regulation of cell growth are shown. Cell-cycle phases are 
noted from G1 to M at the center of the cell (Source : 
Involvements of connexins in carcinogenesis. In: Connexins: a 
guide, Humana Press, 2009). ●, phosphorylation of the 
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carboxy-terminal part of Cx43; cAMP, cyclic adenosine 
monophosphate; cdc25A, cell division cycle 25 homolog A; Cdk, 
cyclin-dependent kinase; Cx, connexin; Cx43P3, 
hyperphosphorylated form of Cx43; cyc, cyclin; Her-2, human 
epidermal growth factor receptor-2; p21, cyclin-dependent 
kinase inhibitor p21Cip1; p27, cyclin-dependent kinase inhibitor 
p27Kip1; PKC, protein kinase C, skp2, S-phase kinase-
associated protein 2; TCF, T-cell factor; Tr-Cx43, truncated 




This study was focused to investigate (1) altered expression 
and localization of Cx32 in human gastric cancer using a tissue 
array-based approach, Helicobacter pylori-induced murine 
gastric tumors, and murine preneoplastic changes (mucous 
metaplasia), (2) the relationship between Cx32 and cell 
proliferation marker Ki67 or cell-cycle regulatory proteins 
p21Cip1 or p27Kip1 using immunohistochemistry in gastric tissues, 
(3) and the relationship between adhesion proteins E-cadherin 
or β-catenin expression and Cx32 expression, using 
immunohistochemistry in gastric tissues. (4) And we examined 
cell proliferation, cell cycle distribution, and levels of the cell 
cycle-regulatory proteins p21Cip1 and p27Kip1 after Cx32 








Altered expression and localization of 






Intercellular communication via gap junctions, composed of 
protein subuints called connexins (Cxs), plays a key role in 
controlling cell growth, differentiation and carcinogenesis. 
Impaired gap junctional intercellular communication has been 
reported in various cancers and diseases. We investigated Cx32 
expression patterns and semiquantitatively assessed Cx32 
expression in cancers and preneoplastic lesions. To determine 
if cell proliferation is correlated with Cx32 expression, we 
evaluated Ki67 expression in a gastric cancer mouse model. In 
human and mouse normal stomach and gastric adenocarcinoma 
tissues were used for immunohistochemical analyses. Cx32 was 
detected at cell-cell (intercellular) contact points in normal 
cells and exhibited punctate intercellular and intracytoplasmic 
staining in cancer cells. The frequency of Cx32 loss of 
expression was significantly higher in human adenocarcinomas 
than in normal stomach. As tumor cells were less differentiated, 
Cx32 expression levels and intercellular and intracytoplasmic 
staining were also significantly lower. The Cx32 expression 
pattern in the mouse gastric cancer model was similar in 
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several important respects to that of human. In mucous 
metaplasia of the mouse stomach, Cx32 was mainly expressed 
in the cytoplasm of epithelial cells. There was also an inverse 
correlation between Cx32 expression and cell proliferation in 
mouse tumors. However, there was no difference in the levels 
of Cx32 mRNA between normal and cancerous tissues. These 
findings suggest that altered Cx32 expression, a loss of 
intercellular Cx32 and a gain of intracytoplasmic Cx32 in the 
form of punctuate “ dot ” , plays an important role in the 





Cell communication through gap junctions regulates basic 
processes such as cell growth and differentiation, and maintains 
homeostasis (Loewenstein and Rose 1992, Vinken et al. 2008). 
Gap junction intercellular communication (GJIC) reflects the 
flux of small (< 1 kDa) and hydrophilic molecules, such as 
glucose, glutamate, and adenosine trisphosphate (ATP), as well 
as ions, through these channels via passive diffusion; in 
contrast large polypeptides and nucleic acids are excluded 
(Vinken et al. 2008, Alexander and Goldberg 2003). Gap 
junctional channels are composed of two connexon complexs in 
adjacent cells, each of which is composed of six connexin (Cx) 
proteins. Individual Cxs are defined and named based on their 
molecular weight and differ in both function and expression 
patterns (Vinken et al. 2008, Willecke et al. 2002).  
Cxs have been previously reported in various types of 
malignant tumors, including breast, liver, colon and esophageal 
tumors (Monaghan et al. 1996, Conklin et al. 2007, Nakashima 
et al. 2004, Kanczuga-Koda et al. 2005b, Hong and Lim 2008, 
Inose et al. 2009). Decrease or loss of Cxs expression has also 
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been reported (Jamieson et al. 1998, Conklin et al. 2007). In 
normal human breast tissue, Cx26 is localized to the 
membranes of luminal cells, whereas epithelial cells of benign 
lesions and lobular carcinoma do not express Cx26 (Jamieson 
et al. 1998, Monaghan et al. 1996). In addition, Conklin et al. 
reported that Cx43 is downregulated at various stages of breast 
cancer progression, including ductal carcinomas in situ, 
infiltrating ductal carcinoma and infiltrating lobular carcinomas 
(Conklin et al. 2007). Although some reports have implicated 
reduced or absent Cx expression in cancer pregression, others 
have suggested that altered subcellular localization of Cx32, 
specifically, intracytoplasmic expression, is involved 
(Nakashima et al. 2004, Hong and Lim 2008, Kanczuga-Koda 
et al. 2005b). Generally Cx is distributed primarily along 
membranes of normal cells, but in hepatocellular carcinoma 
Cx32 is mostly detected in both the cytoplasm and on the cell 
membranes of tumor cells (Nakashima et al. 2004). In 
colorectal cancers, Cx26-positive adenocarcinoma cells exhibit 
primarily cytoplasmic Cx26 (Kanczuga-Koda et al. 2005b, 
Hong and Lim 2008). There is some evidence from 
experimental models that Cx is reduced or absent in tumors. In 
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the mouse, real-time reverse transcription-polymerase chain 
reaction (RT-PCR) and Western blot analyses have shown that 
Cx26, Cx32, Cx40 and/or Cx46 levels are decreased in 
urethane or 4-nitroquinoline 1-oxide-induced lung tumors 
compared to normal lung (Avanzo et al. 2006, Udaka, Miyagi 
and Ito 2007).  
Gastric adenocarcinoma is one of the most prevalent 
malignant neoplasms in the world, particularly in Eastern Asia 
(Parkin, Laara and Muir 1988). The development of gastric 
cancer is believed to occur over a long period of time and 
involve a number of events subsequent to exposure to 
carcinogens and/or Helicobacter pylori (Correa and Houghton 
2007, Correa 1992). In humans, chronic infection with H. pylori 
generally increases the risk of gastric carcinoma by five- to 
six-fold. H. pylori causes chronic gastritis and duodenal and 
gastric ulcer, and is linked gastric cancer and lymphoma 
(Marshall 2003).  
Cx26 and Cx32 are present in normal gastric glands, but their 
expression patterns are different. Cx32 is mainly found along 
the membranes of foveolar cells and Cx26 is predominantly 
found within the cytoplasm of parietal cells (Fink et al. 2006, 
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Radebold et al. 2001, Uchida et al. 1995). In an investigation of 
Cx32 expression in gastritis, intestinal metaplasia and gastric 
carcinoma, Uchida et al. showed that Cx32 expression was 
significantly reduced in epithelial cells with gastritis and 
intestinal metaplasia compared to normal gastric mucosa, and 
was undetectable in carcinoma cells (Uchida et al. 1995). 
However, these studies were limited by the relatively small 
number of cases investigated. Moreover, the potential 
association between altered GJIC and gastric adenocarcinoma 
has not yet been clearly defined. In the present study, we 
investigated altered patterns of Cx32 expression in human 
gastric cancer using a tissue array-based approach. As a 
comparison, we also evaluated Cx32 expression patterns in H. 
pylori-induced gastric tumors. Preneoplastic changes (mucous 
metaplasia) and correlations between the index of Cx32 





MATERIALS AND METHODS 
Preparation of tissue-arrayed human gastric 
cancers  
Tissue-arrayed slides containing gastric adenocarcinomas (n = 
97) and normal gastric tissues (n = 60) were purchased from 
SuperBioChips Laboratories (Seoul, Korea, www.tissue-
array.com) and ISU ABXIS Co., Ltd. (Seoul, Korea, 
tissuearray.pentagen.com). These samples were collected by 
biopsy or during the partial or total gastrostomy of gastric 
cancer patients. Each tissue array spot was classified based on 
the degree of tumor cells differentiation of the adenocarcinomas, 
16 were well differentiated, 16 were moderately differentiated, 
37 were poorly differentiated, and 4 were mucinous; there were 
also 24 signet ring cell carcinomas. Tumors were also classified 
according to the Lauren’s and TNM classification schemes. 
Briefly, adenocarcinomas were classified into intestinal and 
diffuse types according to Lauren’s classification, and were 
further divided into non-invasive or invasive (invading the 
lamina propria, submucosa, muscularis propria, subserosa, 
serosa or adjacent structures), and non-metastatic or 
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metastasized (to regional lymph nodes or distant organs) 
(American Joint Committee on Cancer 2002). 
 
Mice and experimental design 
The experimental protocol for mouse gastric cancer induction 
was as described previously (Han et al. 2002). Male C57BL/6J 
mice (5 weeks old) were purchased from Charles River 
Laboratories (Yokohama, Japan). The mice were housed five 
per cage in a clean rack maintained at room temperature (22°
C-26°C) under a 12-h light/dark illumination cycle. Mice 
were given the 200 ppm N-methyl-N-nitrosourea (Sigma 
Chemical Co., St. Louis, MO, USA) solutions ad libitum in light-
shielded bottles every other week for 10 weeks and then 
inoculated with mouse-adapted H. pylori (SS1) three times 
every other day for six days. After fasting for 24 hours, mice 
were administered a 0.1-mL suspension of H. pylori containing 
1x109 colony-forming units (CFU)/mL (OD450 2.4). The mice 
were sacrificed 38 weeks after the last H. pylori infection. This 
experiment was approved by the Institutional Animal Care and 
Use committee of Seoul National University (SNU-060112-1 
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and SNU-060507-1) and was carried out in accordance with 
institutional guidelines. 
 
Histopathologic examination  
Immediately after sacrifice, mouse stomachs were opened along 
the greater curvature. The stomachs were fixed in neutral-
buffered 10% formalin and processed by standard methods. 
Tissues were embedded in a low-melting-point paraffin, 
sectioned into 4 μm slices, and stained with hematoxylin and 
eosin (H&E). 
Mucin-containing cells were detected by periodic Acid Schiff 
(PAS) staining of replicate serial paraffin sections. 
 
Immunohistochemical staining for Cx32 and Ki67 
Cx32 and Ki67 expressions in mouse and human gastric tissues 
was detected by immunohistochemistry using mouse anti-rat 
Cx32 (Chemicon International Inc., Temecula, CA, USA) and 
rabbit anti-human Ki67 (Novocastra, Newcastle, UK) 
antibodies. Immunoreactive proteins were detected using a 
MOM immunodetection kit (Vector Laboratories, Burlingame, 
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CA, USA) or a Universal DakoCytomation LSAB+ kit 
(DakoCytomation, Carpinteria, CA, USA) in mouse gastric 
tissues as described by the manufacturers. Briefly, after 
dewaxing and rehydrating, the sections were subjected to 
antigen retrieval using an electric Pressure Cooker (Cell 
Marque, Rocklin, CA, USA), and endogenous peroxidase 
activity was quenched with hydrogen peroxide. The slides were 
then washed with phosphate-buffered saline (PBS) and blocked 
using the blocking serum provided in the staining kit. 
Thereafter, slides were incubated overnight at 4°C with 
primary anti-Cx32 (1:200) or anti-Ki67 (1:1000) antibody, 
followed by incubation with biotinylated secondary antibodies 
and horseradish peroxidase-conjugated streptavidin. 3,3 ’ -
Diaminobenzidine tetrahydrochloride (Sigma, St. Louis, MO, 
USA) was used as the chromogen. The sections were 
counterstained with Mayer’s hematoxylin (DakoCytomation, 
Carpinteria, CA, USA) and examined under a light microscope. 
In human gastric tissues, Cx32 staining was performed using 
the BOND-MAX automated immunostainer (Leica 
Microsystems, Wetzlar, Germany) with bond polymer refine 
detection kit (Leica Microsystems, New York City, NY, USA) 
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as described by the manufacturers. 
 
Immunohistochemistry scoring and analysis 
A scoring system was established such that tumor cells in 
which Cx32 staining was detected in 10% or fewer cells were 
defined as negative and those in which staining was detected in 
more than 10% of cells were defined as positive (Kim et al. 
2010, Madore et al. 2010). Positively stained tissues were 
categorized based on localization of Cx32 expression: cell 
membrane and/or cytoplasm. The intensity of  Cx32 staining in 
human and mouse stomach tissues was scored 
semiquantitatively based on the percentage of stained cells and 
their intensities of staining, as described previously (Grizzle 
WE 1998). Staining intensity was rated on a 0-to-3 scale: 0, 
negative; 1, weak positive staining; 2, moderate positive 
staining; 3, strong positive staining. The final semiquantitative 
score was obtained by multiplying the percentage of stained 
cells. Thus, a score of 1 was obtained if 100% of cells stained 
with an intensity of +1 or if 50% of cells stained with an 
intensity of +2. For example, if 10% of tumor cells stained at 0, 
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10% of cells stained at +1, 30% of cells stained at +2, and 50% 
of cells stained at +3, the total score would be 2.2. All samples 
were evaluated and scored without knowledge of sample-
identifying information. 
 
RNA isolation and quantitative real-time RT-PCR 
A quantitative messenger ribonucleic acid (mRNA) expression 
analysis of target genes was performed using a real-time RT-
PCR system. Total RNA was extracted from mouse gastric 
tissue with TRIzol Reagent (Invitrogen Life Technologies, 
Carlsbad, CA, USA) according to manufacturer’s instructions. 
The extracted RNA sample (500 μg) was reversed transcribed 
using an ImProm-IITM reverse transcription system kit 
(Promega, Madison, WI, USA) and the following reaction 
conditions: 25°C for 5 minutes (annealing), 42°C for 60 
minutes (extension), and 70°C for 15 minutes (inactivation). 
The cDNA was analyzed by real-time PCR using SYBR Green 
PCR master mix (Applied Biosystems Inc., Foster City, CA, 
USA) and the following primer pairs: Cx32 forward 5 ’ -
ATCTGCTCTACCCCGGCTATG- 3 ’ , reverse 5 ’ -
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GCAGGCTGAGCATCGGTC GCT-3’ and GAPDH forward 5’
-GACCTCAACTACATGGTCTA-3’, reverse 5’-ACTCCAC 
GACATACTCAGCA-3’ (Udaka et al. 2007). Targets were 
amplified and mRNA was quantified using an ABI 7000 
sequence detection system and the manufacturer’s software 
(Applied Biosystems Inc., Foster City, CA, USA). The amount 
of mRNA was calculated using glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) as the endogenous control. After it 
was confirmed that the dynamic ranges for Cx32 (target) and 
GAPDH (normalizer) amplification were similar, the differences 
(△Ct) between the Ct values of the target and normalizer were 
calculated. The △Ct value of normal stomach was chosen as the 
reference (baseline), and was used to calculate the comparative 
△△Ct value (difference between tumor sample △Ct and 
baseline △Ct). △△Ct values were converted to absolute values 
using the transformation 2△△Ct. 
 
Statistical analysis 
All scores were presented as means ± SEMs. The 
presence/absence of Cx32 expression was analyzed using the 
Chi-square test. Intensity scores were analyzed using 
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Student ’ s t-tests or one-way ANOVAs. The relationship 
between Ki67 and Cx32 expression was analyzed using linear 
regressions and Spearman’s rho correlation tests. Statistical 
analyses were performed using SPSS (SPSS Inc., Chicago, IL, 





Cx32 expression in human gastric cancer and 
normal tissue 
To evaluate Cx32 expression and localization in human gastric 
tumors, we compared gastric carcinoma tissues and normal 
gastric tissues using tissue-arrayed slides. In the gastric 
cancer groups, we found a loss of Cx32 protein compared to 
normal human gastric tissues. Table 1 summarizes the Cx32 
protein loss frequencies in normal human gastric tissues and 
gastric cancer tissues. In tumor tissues, there was a loss of 
Cx32 expressions in 27.8% (27/97) of samples whereas only 
3.33% (2/60) of normal human gastric tissues showed loss of 
Cx32, a difference that was significant (P < 0.01). Cx32 
expression was also analyzed in gastric adenocarcinomas 
subdivided into categories based on WHO and Lauren ’ s 
classifications. The frequency of Cx32 loss was 0% (0/16) in 
well-differentiated adenocarcinomas, 6.25% (1/16) in 
moderately differentiated adenocarcinoma, 29.7% (11/37) in 
poorly differentiated adenocarcinomas, 25.0% (1/4) in 
mucinous adenocarcinomas, and 58.3% (14/24) in signet ring 
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cell carcinomas. Cx32 protein loss frequencies were 
significantly increased in poorly differentiated adenocarcinomas 
and signet ring cell carcinomas compared to normal tissues (all 
P < 0.05). The frequency of Cx32 expression was also 
significantly lower in less-differentiated tumor cells (P < 
0.001). Among tumor Lauren classifications, the frequency of 
Cx32 loss was 8.70% (4/46) in intestinal type and 45.1% 
(23/51) in diffuse type, a difference that was statistically 
significant (P < 0.001). 
 An evaluation of Cx32 protein localization in normal and 
gastric cancer tissues revealed that, in normal stomach tissues, 
Cx32 protein was prominantly localized to cell-cell contact 
sites (intercellular expression) in the membranes of foveolar 
cells (Fig. 1A), but was expressed in cell membranes and/or 
cytoplasm (Fig. 1B). In tumor tissues, the Cx32 protein 
distribution was altered compared to that in normal cells, and 
varied according to the differentiation status of tumor cells. 
Some adenocarcinomas showed mild-to-moderate Cx32 
expression in the cytoplasm (Fig. 1C and D), whereas others 
showed loss of staining in the cell membrane and weak positive 
staining in the cytoplasm (Fig. 1E). Signet ring cell carcinomas 
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were negative for Cx32 (Fig.1F).  
We then analyzed the expression of Cx32 protein according 
to intercellular and intracytoplasmic localization (Table 1), and 
found significant differences between normal tissues and 
cancerous tissues (P < 0.01). Both intercellular and 
intracytoplasmic expression were significantly lower in well-
differentiated, moderately-differentiated, poorly-differentiated, 
mucinous adenocarcinoma and signet ring cell carcinoma 
compared to normal tissues respectively (all P < 0.05). 
Intercelluar and intracytoplasmic expression of Cx32 was also 
significantly lower in less-differentiated tumor cells (P < 0.05), 
and was eventually lost entirely in least-differentiated tumor 
cells. As a consequence, overall Cx32 expression was 
significantly lower in less-differentiated tumor cells. We found 
no significant difference in intercellular expression between 
intestinal and diffuse tumor types. However, an examination of 
expression patterns according to tumor invasion status showed 
a significant loss of total and intercellular Cx32 expression as 
the tumor invaded from the mucosa to the serosa (P = 0.005 
and P = 0.047 respectively). Consistent with those results, an 
analysis of staining, intensity showed that Cx32 scores were 
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significantly higher in normal stomach tissues (2.05 ± 0.07) 
than in tumor cells (1.27 ± 0.06; P < 0.01), and were lower in 




Table 1. Loss of Cx32 expression and Cx32 cellular localization 
in normal human gastric tissues and adenocarcinoma 
Classification 
Loss of Cx32 
expression (%) 
Cx32 cellular localization 
Intercellular Intracytoplasmic 
WHO    
Normal (n = 60) 2 (3.33%)† 42 (70.0%)‡ 16 (26.7%) 
WD (n = 16) 0 (0%) 3 (18.7%)* 13 (81.3%) 
MD (n = 16) 1 (6.25%) 4 (25.0%)* 11 (68.8%) 
PD (n = 37) 11 (29.7%)* 1 (2.70%)* 25 (67.6%) 
Mucinous (n = 4) 1 (25.0%) 0 (0%)* 3 (75.0%) 
SRC (n = 24) 14 (58.3%)* 1 (4.17%)* 9 (37.5%) 
Lauren    
Intestinal(n = 46) 4 (8.70%)§ 8 (17.4%)¶ 34 (73.9%) 
Diffuse (n = 51) 23 (45.1%) 1 (1.96%) 27 (52.9%) 
WD, well-differentiated adenocarcinoma; MD, moderately 
differentiated adenocarcinoma; PD, poorly differentiated 
adenocarcinoma; Mucionus, mucinous adenocarcinoma; SRC, 
signet ring cell carcinoma. †P < 0.001 vs. cancer, ‡P < 0.01 vs. 
cancer, §P < 0.01 vs. diffuse type, ¶P > 0.05 vs. diffuse type, 







Figure 1. Immunohistochemical detection of Cx32 expression in 
human tissue-arrayed normal stomach (A and B) and gastric 
adenocarcinoma (C-F).  
Distribution and intensity of Cx32 expression was altered in 
tumor cells: intercellular expression of Cx32 in foveolar cells 
(A) and intracytoplasmic expression (B). Cx32 is strongly 




Cx32 expression in mouse H. pylori–induced 
gastric tumors  
We next analyzed Cx32 protein expression in normal and 
gastric cancer tissues in the H. pylori-induced gastric cancer 
mouse model. The Cx32 protein loss frequency by group is 
summarized in Table 2. The Frequency of Cx32 loss was 0% 
(0/10) in normal stomach, 10% (1/10) in adenoma and 50% 
(5/10) in adenocarcinoma. Compared to normal tissues, the loss 
of Cx32 expression in adenocarcinoma was significant (P= 
0.033) whereas that for adenomas was not. Cx32 expression 
decreased significantly as tumor became progressively more 
malignant, reflecting the transition from normal to adenomas 
and then to adenocarcinomas (P = 0.013). 
To determine if the decrease in total and intercellular Cx32 
expression observed in human gastric cancer tissues also 
occurred in mouse gastric cancer models and to determine of 
Cx32 subcellular localization, we examined Cx32 expression in 
normal murine stomach tissues (Fig. 2A and B) and gastric 
cancer tissues (Fig. 2E and F). 
Mouse gastric tumors were diagnosed as adenoma or 
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adenocarcinoma on the basis of cytologic criteria as well as the 
presence or absence of invasion to the submucosa. Adenomas 
consisted of acini and tubules lined with cuboidal or polygonal 
cells without submucosal invasion. Adenocarcinomas showed 
invasion into the submucosa, and their tumor cells were 
arranged in acini, tubule types or solid patterns (Fig. 2E). 
Neoplastic cells that showed acinar or solid types had high 
nuclei/cytoplasm ratios and showed frequent mitotic figures. 
Tumor cells that were arranged in tubules or cysts had 
abundant cytoplasm, and some formed branching structures 
(Fig. 2F). 
We also investigated the localization of Cx32 expression in 
normal mouse stomach and tumor tissues. In normal stomachs, 
the membranes of foveolar cells showed strong Cx32positivity. 
Cx32 was strongly expressed on the surface of gastric pit, but 
was not expressed or was expressed weakly in the base area 
(Fig. 2C). Cx32 staining was observed in the cell membranes 
and cytoplasm of deep glandular cells of the pylorus (Fig. 2D). 
In adenomas, epithelial cells arranged in acinar or tubular 
patterns exhibited strong Cx32 expression in the form of dots 
in cell membranes and cytoplasm. Strong punctate Cx32 
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expression was also evident in the cell membranes and 
cytoplasm of epithelial cells that constituted the branched 
tubules or cysts of adenocarcinomas, (Fig. 2G). However, Cx32 
staining was lost in solid and acinar type cancers (Fig. 2H). We 
also analyzed the location of Cx32 protein expression in mouse 
tissues. We found no significant difference in the intercellular 
expression of Cx32 between adenomas and normal tissues. 
However, the intercellular expression of Cx32 was significantly 
decreased in adenocarcinomas compared to normal tissues (P = 
0.003). Consistent with this, intercellular Cx32 expression 
significantly decreased as the tumor progressed to a more 
malignant form (P = 0.02). An analysis of staining intensity 
scores in mouse tissues reinforced these findings. There was 
no significant difference in scores between adenomas (2.33 ± 
0.07) and normal tissues (2.42 ± 0.06), but Cx32 intensity 
scores of adenocarcinoma tissues (0.78 ± 0.09) was decreased 
compared to normal tissues (P< 0.01). Moreover, Cx32 
expression intensity scores decreased as mouse tumor cells 
became less differentiated (P < 0.01).  
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Table 2.  Cx32 expression in normal murine gastric tissues, 
adenocarcinoma and mucous metaplasia 
* P < 0.05 vs. normal tissue. 
 
Classification 
Loss of Cx32 
expression (%) 
Cx32 cellular localization 
Intercellular Intracytoplasmic 
Normal (n=10) 0 (0%) 10 (100%) 0 (0%) 
Adenoma (n=10) 1 (10%) 8 (80%) 1 (10%) 
Adenocarcinoma 
(n=10) 
5 (50%)* 3 (30%)* 2 (20%) 
Mucous metaplasia 
(n=10) 







Figure 2. Histology and immunohistochemical detection of Cx32 
in pyloric regions of normal mouse stomach (A, B, C and D) and 
gastric adenocarcinoma (E, F, G and H).  
Immunohistochemistry shows that Cx32 expression in surface 
cells in the gastric pit is strong, whereas that in basal cells is 
weak (C). Deep pyloric glandular cells show punctuate Cx32 
staining in membranes and/or cytoplasm (D). In neoplastic cells 
arranged in irregularly glandular patterns lined by stratified 
epithelial cells, both intercellular and intracytoplasmic punctate 
staining was strongly observed (G). In cancer cells that showed 
nests or acinar patterns (dashed line), Cx32 is absent (H). Bar 




Cx32 expression in mouse H. pylori–induced 
gastric preneoplastic lesions 
To examine Cx32 expression in preneoplastic lesions, we 
analyzed Cx32 in mucous metaplasia of mouse tissues using 
immunohistochemistry. The frequency of Cx32 loss was 20% 
(2/10) in mucous metaplasia compared to normal stomach 
tissues (Table 2). In normal pyloric foveolar cells, Cx32 protein 
was observed in the form of dots in the lateral aspects of cell 
membranes (Fig. 3C). However, in mucous metaplasia, Cx32 
protein was observed in the form of dots in the base of 
metaplastic epithelial cell cytoplasm (Fig. 3F and G). Although 
differences in intercellular expression of Cx32 between normal 
stomach tissues and mucous cells were insignificant, the Cx32 
intensity scores of mucous metaplastic epithelial cells (1.66 ± 
0.07) were significantly lower than those of normal stomach 








Figure 3. Histology and immunohistochemical detection of Cx32 
in normal mouse stomach and preneoplastic lesions.  
Normal foveolar epitheliums (A) showed PAS-positive (B) and 
Cx32 punctate immunostaining in the lateral portion of 
membrane (C, arrow). Mucous metaplasia showed a loss of 
parietal cells and foamy changes (D). These mucous cells were 
positive for neutral mucin based on PAS staining (E, arrow). In 
mucous metaplasia, Cx32 is detected mainly as dots form in the 
base of cytoplasm (F); a higer magnification is shown in G. Bar 
= 50 μm. 
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Correlation between cell proliferation and Cx32 
expression in mouse stomach tissue 
Serial sections of tissues were co-immunostained for Cx32 and 
the proliferative marker Ki67 to examine the relationship 
between cell proliferation and Cx32 expressions. Ki67 
expression was detected in nuclei of the upper-mid portion of 
the fundus and in nuclei of the sub-basal zone of the pylorus in 
normal stomach tissues (Fig. 4A). Compared to normal tissues, 
Ki67-positive cells in adenocarcinomas were increased and 
irregularly distributed (Fig. 4B). Among Ki67-positive cells, 
Cx32 expression was negative (Fig. 4C and D). As shown in Fig 
4E, a plot of the ratio of Ki67-positive cells against Cx32 
intensity reveals an inverse correlation (Kendall τ= -0.644 
p= 0.01; Spearman r=-0.697, p= 0.03; linear regression 
r2=0.45, p=0.03). That is the large the number of Ki67-
positive cells, the lower the intensity of Cx32 staining. Thus, 









Figure 4. Correlation between Ki-67 and Cx32 expression in 
mouse tissue.  
Ki67-positive cells were found in the basal zone of normal 
pylorus (A) and were irregularly distributed in adenocarcinoma 
(B). Foveolar cells stained strongly for Cx32 protein in the cell 
membrane (C). Reduced intracytoplasmic expressin was 
observed in adenocarcinoma (D). A tendency for Ki67-positive 
cells to exhibit no staining for Cx32 is reflected in the inverse 
correlation between Ki67 staining and Cx32 (E: Kendall τ= -




Semiquantitiative analysis of Cx32 mRNA in mouse 
stomach tissue 
To investigate differences in the levels of Cx32 mRNA between 
normal murine stomach tissues and gastric cancer tissues, we 
used real-time RT-PCR as described in Materials and Methods. 
Our results showed that the relative amount of Cx32 mRNA in 
normal tissues was 0.99 ± 0.02 (n=6) and that of 
adenocarcinomas was 0.97 ± 0.01 (n = 5), a difference that 





We have provided evidence of altered expression of Cx32 in 
human gastric cancers using immunohistochemistry. The 
results obtained from human gastric adenocarcinomas were 
similar in many respect to those obtained in the H. pylori-
induced mouse gastric cancer model. We also investigated Cx32 
expression in preneoplastic lesions and related Cx32 
expression with cell proliferation. 
We found that Cx32 is localized at cell-cell contact areas in 
normal epithelial cells, whereas in tumor cells, this intercellular 
expression is lost and Cx32 protein staining is detected as 
intracytoplasmic dots. Similar to these results, 
immunohistochemical analysis of Cx expression in 
hepatocellular carcinoma and colorectal carcinoma showed the 
presence of Cx protein in the form of dots in both cell 
membrane and cytoplasm (Nakashima et al. 2004, Kanczuga-
Koda et al. 2005b). Our comparative study using mouse gastric 
tissues also provided convincing evidence of altered Cx32 
expression, showing a significant loss of Cx32 expression in 
adenocarcinomas compared to normal tissues. As human gastric 
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tumors progressed to more undifferentiated stages, the 
intercellular and intracytoplasmic expression and intensity of 
Cx32 decreased significantly, and was eventually lost. These 
results are consistent with the idea that Cx32 plays an 
important role in the transformation of glandular epithelial cells 
and progression of gastric cancers.  
Some studies have reported results that diverge from those 
reported here. Inose et al. reported that Cx26 was not 
detectable in normal esophageal squamous cells but was 
expressed in the cytoplasm of cancer cells (Inose et al. 2009). 
An investigation of Cx32 and Cx43 expression in normal tissues 
and human prostate cancer tissue showed that while normal 
prostate epithelial cells expressed only Cx32, prostate cancer 
cells expressed both Cx32 and Cx43 (Mehta et al. 1999). Thus, 
the expression pattern of Cx may vary according to tumor type 
and Cx isoform.  
Our results showed that there was a tendency for Cx32 
expression to decrease compared to normal tissues as the 
tumor invaded from the submucosa to the serosa. Hong et al. 
reported a significant positive correlation between reduced 
intercellular Cx26 and tumor invasion (Hong and Lim 2008). 
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Although more studies are needed, this suggests that Cx32 may 
play a role in preventing the invasion of gastric cancer to the 
submucosa or serosa. In esophageal cancer, abnormal 
expression of Cx26 protein may correlate with tumor 
metastasis and poor prognosis (Inose et al. 2009). Our 
observation that altered Cx32 expression is significantly 
correlated with serosal invasion suggests that Cx32 protein has 
a supportive effect on gastric cancer growth rate. 
The dysfunction or loss of membrane proteins such as Cx, 
E-cadherin and β-catenin is related to tumor malignancy and 
tends to occur in undifferentiated carcinomas (Shimoyama and 
Hirohashi 1991b, Jinn, Ichioka and Marumo 1998, Shimoyama 
and Hirohashi 1991a, Ogawa et al. 1999, Takayama et al. 1996). 
E-cadherin maintains intercellular adherence junctions and β-
catenin connects E-cadherin to the cytoskeleton. Given that 
cell-cell adhesion is necessary for GJIC, correlations between 
Cx and E-cadherin or β-catenin have been described, but 
thses relationships remain unclear. In human lung cancer, a 
concurrent reduction in E-cadherin and Cx43 expression is 
significantly associated with differentiation and progression, 
and exogenous expression of Cx43 in human pulmonary 
65 
 
carcinoma cells significantly induces E-cadherin expression 
(Xu et al. 2008). On the basis of results obtained using Cx32-
null mice treated with N-nitrosodiethylamine and Phenobarbital, 
Schwarz et al. suggested that the loss of Cx32 function and 
mutation of β-catenin were important during 
hepatocarcinogenesis (Schwarz et al. 2003).  
Because neoplastic or preneoplastic cells showed alterated 
Cx expression, we investigated the association between Cx and 
cell proliferation in mouse gastric tumors by 
immunohistochemically examining the expression of the Ki67 
nuclear antigen, which is expressed in all proliferating cells 
during late G1, S, M and G2 phases. Our demonstration that 
Cx32 expression was low in Ki67-positive cells is in consistent 
with the previous demonstration of a possible inverse 
relationship between Cx43 expression and cell proliferation in 
canine bone tumors (Sanches et al. 2009). In addition, knocking 
down Cx32 expression in rat hepatoma cell line using RNA 
interference has been showed to increase proliferation, 
providing support for a causal relationship between Cx32 
expression and proliferative activity (Edwards et al. 2008). 
Taken together with the observation, that expression of 
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proliferation markers in various cancer samples correlates with 
mitotic activity and survival (Bouzubar et al. 1989, Wang, Luo 
and Wang 2006). And the inverse relationship between 
proliferation and Cx expression suggests that Cx32 expression 
might be an indicator of carcinogenesis potential, and as such 
may serve as an additional cancer biomarker. 
No statistically significant differences were seen in Cx32 
mRNA expression in adenocarcinomas compared to normal 
stomach tissues in the mouse gastric cancer model. This agrees 
with a previous report that showed no significant differences in 
Cx mRNA levels between normal tissues and tumors of liver or 
bone (Krutovskikh et al. 1994, Sanches et al. 2009). However, 
in mouse lung tissues, differences in expression of Cx26, 32, 
and 40 between normal tissues and tumors have been reported 
depending on tumor size (Udaka et al. 2007, Avanzo et al. 
2006). One possible interpretation of the present result is that 
aberrant localization of Cx32 protein, and not a reduction in 
expression per se, could be responsible for the observed 
dysfunction of the GJIC. Expression of Cx protein or mRNA 
does not necessarily reflect the functional activities of Cxs. 
Further functional examinations, such as dye transfer studies, 
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are required to confirm the presence of functional channels. 
Another possible interpretation is that the Cx mRNA is 
transcribed but not translated. A number of studies have 
indicated that Cxs, in particular, may express large amounts of 
message without actually producing any protein (Vinken et al. 
2009). For example, Anderson et al reported that Cx43 
downregulation during skeletal muscle development is 
accomplished by two related microRNAs, miR-206 and miR-1, 
that inhibit the expression of Cx43 protein during myoblast 
differentiation without altering Cx43 mRNA levels (Anderson, 
Catoe and Werner 2006). Our immunohistochemistry findings 
may not necessarily have reflected the amount of mRNA 
translated. Further investigations are required to determine 
whether microRNAs are upregulated and serve to inhibit the 
translation of mRNAs to produce Cx32 protein. Lastly, while we 
used total mass to extract mRNA for quantitative real-time 
RT-PCR, only malignant tumor cells are estimated by 
immunohistochemistry when viewing the histological results. A 
clearer definition of this relationship will require additional 
studies that can precisely determine the amount of Cx mRNA in 
tumor and normal tissues through microdissection or an in situ 
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RT-PCR that would prevent contamination from non-malignant 
cells. 
Various experimental data have shown that each step leading 
to the establishment of GJIC can be altered and induce the loss 
of junctional communication. Possible mechanisms include lack 
of transcription of Cx genes; lack of translation of Cx mRNA; 
lack of membrane trafficking, leading to an accumulation of Cx 
proteins in the cytoplasm; and lack of cell-cell recognition 
preventing the establishment of junctional intercellular 
communication (Cronier et al. 2009). Our results support the 
hypotheses that an accumulation of Cx protein in cytoplasm 
and/or lack of translation of Cx mRNA lead to altered Cx 
expression. Additional theories have been introduced to explain 
altered Cx expression. For examples, the presence of 
phosphorylated Cx43 in lung tumors suggests an association of 
Cx43 phosphorylation with lung tumorigenesis (Udaka et al. 
2007). Additional studies will be needed to confirm the role of 
Cx during carcinogenesis. 
In conclusion, the disappearance or reduction in intercellular 
Cx32 staining in gastric adenocarcinoma was associated with 
cell proliferation, and intracytoplasmic staining of Cx32 was 
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observed not only in adenocarcinoma and adenoma but also in 
mucous metaplasia. These findings suggest that the altered 
Cx32 expression, specifically, the loss of intercellular Cx32 and 
the gain of intracytoplasmic Cx32 plays an important role in the 








Connexin32 inhibits gastric carcinogenesis 
through cell cycle arrest and altered 





Gap junctions and their structural proteins, connexins (Cxs), 
have been implicated in carcinogenesis. Not only connexins but 
also cell adhesion-associated proteins play a role in 
differentiation, proliferation and homeostasis. Aberrant 
expression of adhesion proteins and connexins has been 
described in diverse tumors. Also, abnormal expressions of cell 
cycle-regulatory proteins are frequently observed in various 
cancers. To explore the involvement of Cx32 in gastric 
carcinogenesis, immunochemical analysis of Cx32 and 
proliferation marker Ki67 using tissue-microarrayed human 
gastric cancer and normal tissues was performed. And we 
evaluated the relationship between expression of cell cycle-
regulatory proteins such as p21Cip1 and p27Kip1 or adhesion 
protein E-cadherin and β-catenin and Cx32 expression in 
human gastric cancers using immunohistochemistry. In addition, 
after Cx32 overexpression in the human gastric cell line AGS, 
cell proliferation, cell cycle analyses, and p21Cip1 and p27Kip1 
expression levels were examined by bromodeoxyuridine assay, 
flow cytometry, real-time RT-PCR, and western blotting. 
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Immunohistochemical study noted a strong inverse correlation 
between Cx32 and Ki67 expression pattern as well as their 
location. Moreover, as the Cx32 expression changed from 
normal membranous expression to cytoplasmic expression or 
was lost, the p21Cip1- and p27Kip1-positive cell rate decreased 
(negative staining). We found a statistically significant positive 
correlation between Cx32 and E-cadherin or β-catenin 
expression in gastric tissues. In vitro, overexpression of Cx32 
in AGS cells inhibited cell proliferation significantly. G1 arrest, 
up-regulation of cell cycle-regulatory proteins p21Cip1 and 
p27Kip1 were also found at both mRNA and protein levels. Taken 
together, Cx32 plays some roles in gastric cancer development 
by inhibiting gastric cancer cell proliferation through cell cycle 





Gastric cancer is one of the most important causes of cancer-
related death worldwide and remains a major public health 
concern in eastern Asian countries, including Korea and Japan 
(Hohenberger and Gretschel 2003, Smith et al. 2006). In Korea, 
gastric cancer has been the most common type of cancer for 
the last ten years, causing 56.8 deaths per 100,000 individuals 
annually (Jung et al. 2011). The development of gastric cancer 
in response to exposure to carcinogens and/or Helicobacter 
pylori is believed to occur over a long period of time and 
involve a number of events (Correa 1992, Correa and Houghton 
2007). Disruption of the balance between cell proliferation and 
apoptosis is an important driving force of gastric cancer 
development (Kwon et al. 2012, Crabtree et al. 2004). Although 
our understanding of gastric cancer has improved considerably, 
the precise mechanisms underlying gastric cancer progression 
remain incompletely understood.  
Gap junction channels, which are localized to cell-cell contact 
sites, are composed of connexins (Cxs) and mediate the 
intercellular flux of metabolites, nutrients, and second 
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messengers (Vinken et al. 2008, Laird 2006, Mroue, El-Sabban 
and Talhouk 2011). This gap junction intercellular 
communication and Cxs play important roles in organ/tissue 
homeostasis and cell differentiation (Alexander and Goldberg 
2003, Laird 2006, Vinken et al. 2008). Individual Cxs are 
defined and named based on their molecular weight and differ in 
both function and expression patterns (Mroue et al. 2011, 
Vinken et al. 2008, Willecke et al. 2002). Cx26 and Cx32 are 
the main types of stomach Cxs (Radebold et al. 2001, Uchida et 
al. 1995), whereas colonic and rectal epithelial cells primarily 
express Cx26 (Kanczuga-Koda et al. 2005b).  
Abnormal patterns of Cx expression, such as decreases, loss 
or abnormal subcellular localizations, have been reported in 
various human tumors (Conklin et al. 2007, Hong and Lim 2008, 
Huang et al. 1998, Kanczuga-Koda et al. 2005b, Nakashima et 
al. 2004, Uchida et al. 1995). Recently, we reported that 
localization of Cx32 expression altered from cell membranes to 
the cytoplasm or its expression was altogether lost in gastric 
cancer in relation to the degree of tumor cell differentiation 
(Jee et al. 2011). Moreover, decreased expression of several 
types of Cxs has been reported in chemically induced mouse 
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lung tumors (Avanzo et al. 2006, Udaka et al. 2007). 
Accumulating evidence has demonstrated a role for Cxs in 
cell proliferation. A comparison of the cellular proliferation with 
the Cx43 levels has demonstrated a possible inverse correlation 
in canine bone tumors (Sanches et al. 2009). Consistent with 
this, knocking down Cx32 expression was shown to increase 
cell proliferation in rat hepatoma cell line (Edwards et al. 2008), 
and Cx43 overexpression was found to decrease proliferation 
of human lung cancer-derived cell lines (Xu et al. 2008). It is 
generally recognized that tumors develop and progress through 
uncontrolled cell growth due to abnormalities in the cell cycle 
(Hunter and Pines 1994, Ford HL 2004).  
In this study, we examined the expression of Cx32 and that 
of the proliferation marker Ki67 in tissue-microarrayed human 
gastric tissues and investigated the correlation between their 
expression patterns. And we evaluated the relationship between 
expression of cell cycle-regulatory proteins such as p21Cip1 
and p27Kip1 or adhesion protein E-cadherin and β-catenin and 
Cx32 expression in human gastric cancers using 
immunohistochemistry. We then examined cell proliferation, cell 
cycle distribution, and cell cycle-regulatory proteins p21Cip1 
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and p27Kip1 expression levels after Cx32 overexpression in the 




MATERIALS AND METHODS 
Immunohistochemical staining  
Tissue-microarrayed slides containing a total of 105 gastric 
adenocarcinoma and 62 normal gastric tissues, purchased from 
SuperBioChips Laboratories (Seoul, Korea) and ISU ABXIS Co., 
Ltd. (Seoul, Korea) were used for immunohistochemistry.  
Table 3 summerizes the antibodies used in this study. The 
degrees and pattern of Cx32, Ki67, E-cadherin, β-catenin, 
Ki67, p21Cip1 and p27Kip1 expressions were studied 
immunohistochemically in replicate sections of tissue-
microarrayed slides, using mouse anti-rat Cx32 (Chemicon 
International Inc., Temecula, CA, USA), rabbit anti-human Ki67 
(Dakocytomation, Glostrup, Denmark), mouse anti-human E-
cadherin (BD Transduction LaboratoriesTM, CA, USA), mouse 
anti-mouse β-catenin (BD Transduction LaboratoriesTM, CA, 
USA), p21Cip1 (Santa Cruz biotechnology Inc., CA, USA), and 
p27Kip1 (Oncogene, Cambridges, Mass., USA) antibodies. 
Immunoreactive proteins were detected using a Bond Polymer 
Refine Detection kit and BOND-MAX automated immunostainer 
(Leica Microsystems, New York City, NY, USA). Briefly, after 
78 
 
dewaxing and rehydrating, the sections were subjected to an 
antigen-retrieval procedure, and endogenous peroxidase 
activity was quenched with hydrogen peroxide. The slides were 
then washed with phosphate-buffered saline (PBS) and blocked 
using the blocking serum provided in the staining kit. 
Thereafter, slides were incubated with primary anti-Cx32 and 
anti-Ki67, anti-E-cadherin, anti-β-catenin, anti-p21Cip1, or 
anti-p27 Kip1 antibodies followed by incubation with a post-
primary blocker and polymer, as described by the 
manufacturers. 3,3’-diaminobenzidine was used as the 
chromogen. The sections were counterstained with Mayer’s 
hematoxylin (DakoCytomation, Carpinteria, CA, USA) and 










Connexin32 1:200 Membranous Cytoplasmic or loss 
Ki67 1:100 Nuclear 
Nuclear expression 
increase 
E-cadherin 1:500 Membranous Cytoplasmic or loss 
β-catenin 1:800 Membranous 
Cytoplasmic or 
Nuclear 
p21Cip1 1:200 Nuclear 
Nuclear expression 
decrease 






Immunohistochemistry scoring and analysis  
For immunohistochemical analyses, a total of approximately 
1,000 tumor or normal cells from each microarrayed spot were 
evaluated. Cx32 expression patterns were classified into three 
categories: normal membranous expression, cytoplasmic 
expression or loss (Jee et al. 2011). A spot with less than 10% 
Cx32 was positivity regarded as negative (loss). To determine 
the Ki67-labeling index, epithelial cells were separated into 
positive cells and negative cells. The Ki67-labeling index (%) 
was determined by dividing the number of positive cells by the 
total number of cells, and multiplying by 100. E-cadherin 
expression was applied according to the systems as follows: no 
staining; cytoplasmic expression; normal membranous 
expression and β-catenin expression was applied according to 
the systems as follows: nuclear; cytoplasmic expression; 
normal membranous expression (Almeida et al. 2010, Zhang et 
al. 2010, Kim, Han and Lim 2011, Jawhari et al. 1997). p21Cip1 
expression was graded as negative (≤10%) or positive (≥10% 
of tumor cells stained) (Natsugoe et al. 1999, Liu et al. 2001). 
The p27Kip1 immunoreactivity was considered as high if the 
percentage of positive cells was over 30%, low if the 
81 
 
percentage of positive cells was 5-30%, or negative if the 
percentage of positive cells was less than 5%.  
 
Cell culture and Cx32 transfection 
The AGS human gastric cancer cell line was purchased from the 
Korean Cell Line Bank (Seoul, Korea) and cultured in RPMI-
1640 (Gibco, Grand Island, NY, USA) containing 10% fetal 
bovine serum (Gibco, Grand Island, NY, USA), and antibiotic-
antimycotic (Invitrogen Biotechnology, Grand Island, NY, USA) 
at 37°C in a humidified atmosphere of 5% CO2.  
A cDNA insert containing the entire coding region of human 
Cx32 (NM_000166) (Kumar and Gilula 1986) was subcloned 
into the Xho I - Hind III site of the expression vector pEGFP-
N1 (Clontech Laboratories, Inc., Mountain View, CA, USA). The 
sequence of the resulting Cx32 expression plasmid (pEGFP-
N1-Cx32) was confirmed by DNA sequencing. AGS cells were 
transfected with pEGFP-N1-Cx32 or pEGFP-N1 (control 
vector) using Metafectene Pro transfection reagent according 
to the manufacturer ’ s instructions (Biontex Laboratories, 
Martinsried, Germany). After selection for 14 days with 1 
mg/ml of G-418 (Sigma-Aldrich Co., St. Louis, MD, USA), a 
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single-cell clone was established and screened for Cx32 
expression by immunoblotting.  
 
Cell proliferation and cell cycle analysis 
Cell proliferation was measured using bromodeoxyuridine 
(BrdU)-based cell proliferation assay (Millipore, Temecula, CA, 
USA) according to the manufacturer’s instructions. Briefly, 
during the final 2 hours incubation, BrdU was added to cells (2 
x 105 cells/mL) grown on culture dishes. After fixing and 
washing, cells were incubated with a mouse anti-BrdU 
monoclonal antibody, followed by incubation with a peroxidase-
conjugated goat anti-mouse IgG secondary antibody and a 
peroxidase substrate. Thereafter, absorbance at 450/550nm 
was monitored using a spectrophotometer microplate reader 
(Molecular Devices, Sunnyvale, CA, USA). 
For cell cycle analysis, AGS cells wild-type, AGS cells 
transfected with control vector, and AGS cells transfected with 
Cx32 vector were trypsinized, and then fixed and incubating at 
-20°C. After washing, the cells were incubated in phosphate-
buffered saline containing RNase for 30 min at 37°C. Then, a 
solution of propidium iodide was added to the cell suspension, 
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and the cells were analyzed using a FACSCalibur Flow 
Cytometer (Becton Dickinson Biosciences, San Jose, CA, USA).  
 
Western blotting 
For preparation of total protein lysates, AGS cells of three 
groups were lysed (1 M Tris-HCl, 5 M NaCl, 0.5 M EDTA, and 
NP-40) and microcentrifuged. The supernatants were 
separated by electrophoresis on polyacrylamide gels, 
transferred to polyvinylidene fluoride membranes (Bio-Rad 
Laboratories, Hercules, CA, USA), and probed with antibodies 
against Cx32, p21Cip1, or p27Kip1. The membranes were 
incubated with horseradish peroxidase-conjugated goat anti-
rabbit IgG antibody (GE Healthcare UK Limited, 
Buckinghamshire, UK) or horse anti-mouse IgG antibody 
(Vector Laboratories, Burlingame, CA, USA), and 
immunoreactive bands were identified. Equal protein loading 
was ensured by reprobing membranes with an antibody directed 





RNA isolaton and quantitative real-time RT-PCR  
The total RNA from transfected cells was extracted by RNeasy 
Plus Mini Kit (Qiagen, Hilden, Germany) according to 
manufacturer’s instructions. About 1μg of total RNA from 
each sample was subjected to cDNA synthesis using 
QuantiTeck Reverse Transcriptation Kit (Qiagen, Hilden, 
Germany) according to manufacturer ’ s instructions. The 
cDNA was analyzed by real-time polymerase chain reaction 
(PCR) using Rotor-Gene SYBR Green PCR Master Mix (Qiagen, 
Hilden, Germany) and the following primer pairs: p21Cip1 
forward 5’-TCCAGCGACCTTCCTCATC CAC-3’, reverse 
5’-TCCATAGCCTCTACTGCCACCATC-3’; p27Kip1 forward 
5 ’ -CGCTCGCCAGTCCATT-3 ’ , reverse 5 ’ -
ACAAAACCGAACAAAA CAAAG-3’; β-actin forward 5’-
CCACACTGTGCCCATCTACG-3 ’ ; reverse 5 ’ -AGGATCT 
TCATGAGGTAGTCAGT CAG-3’. Targets were amplified and 
mRNA was quantified using a Rotor-Gene Q and the 
manufacturer ’ s software (Qiagen, Hilden, Germany). The 





Statistical analysis  
Statistical analyses were performed using SPSS Statistics 
(version 18.0; SPSS Inc., Chicago, IL, USA). Proliferation 
indexes (Ki67 labeling indexes) were expressed as means ± 
standard deviations; data were compared using a two-tailed 
Student’s t-test. The relationship between Ki67, E-cadherin, 
β-catenin, p21Cip1, or p27Kip1and Cx32 expression was 
analyzed using Chi-square and Spearman’s rho correlation 
tests. In tests on AGS cells, the data were expressed as means 
± standard deviations of at least three independent 
experiments (n = 3); the data were compared using an 
unpaired two-tailed Student’s t-test. P-values less than 0.05 




Cx32 expression in human gastric cancer and 
normal tissue  
We recently investigated Cx32 expression in human normal as 
well as gastric cancer tissues (Jee et al. 2011). As previously 
found, normal gastric mucosa predominantly showed 
intercellular Cx32 expression (Fig. 5A), whereas cytoplasmic 
expression (Fig. 5B) and loss of expression (Fig. 5C) were 
often noted in cancer tissues. The expression of Cx32 at 
intercellular junctions gradually decreased, whereas 
cytoplasmic expression or loss of expression increased in 
proportion to the degree of neoplastic cell differentiation.  
 
The relationship between Cx32 and Ki67 
expression in human gastric cancer and normal 
tissue 
Nuclear Ki67 expression was evident in both normal (Fig. 5D) 
and cancer tissues (Fig. 5E and F). Our results showed that 
10.15% ± 7.57% of cells in normal tissues were Ki67-positive 
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compared with 18.99% ± 17.41% in gastric cancer tissue. Thus, 
the percentage of Ki67-positive cells was significantly 
increased in gastric cancer (P < 0.01).  
An examination of Ki67-positivity in relation to the pattern of 
Cx32 expression in normal gastric tissues and carcinoma tissue 
showed an inverse correlation between Cx32 and Ki67 
expression (Spearman rho = -0.421; P < 0.01) (Fig. 6). This 
correlation held for normal tissue (Spearman rho = -0.269; P 
= 0.034) and cancer tissue (Spearman rho = -0.430; P < 0.01) 
analyzed separately. Specifically, the frequency of Ki67-
positive cells was increased as Cx32 localization shifted from a 
membranous to cytoplasmic pattern, and was further increased 








Figure 5. Immunohistochemical stainingfor Cx32 and Ki67 in 
normal gastric tissues (A and D) and gastric cancer tissues (B, C, 
E, and F).  
A, normal gastric mucosa showed intercellular Cx32 
expression; B, The cancer cells in moderately differentiated 
adenocarcinoma showed intracytoplasmic Cx32 expression; C, 
The cancer cells in poorly differentiated adenocarcinoma 
showed negative staining; D, normal gastric mucosa showed 
negative staining for Ki67 E, The cancer cells in moderately 
differentiated adenocarcinoma showed nuclear expression; F, 
The cancer cells in signet ring cell carcinoma showed nuclear 







Figure 6. The relationship between Ki67 and Cx32 expression in 
normal gastric tissues and cancer tissues.  
There is an inverse correlation between Ki67 positivity and 






The relationship between the cell adhesion 
proteins, E-cadherin and ß-catenin, and Cx32 
expression 
Firstly, we investigated the expression and distribution of E-
cadherin, a well-known cell adhesion molecule, in gastric 
normal tissue and cancer tissue. E-cadherin was expressed at 
the membrane of most of the epithelial cells in normal tissue 
(Fig. 7D), while it showed only cytoplasmic expression without 
membranous expression in epithelial cells (Fig. 7E) or it was 
not expressed at all (Fig. 7F), indicating different pattern of 
expression. The loss rate of E-cadherin expression in gastric 
normal tissue was 4.84% (3/62), whereas it was 13.3% 
(14/105) in gastric cancer tissue. The loss rate of E-cadherin 
membranous expression in gastric normal tissue was 14.5% 
(9/62), whereas it was 83.8% (88/105) in gastric cancer tissue. 
The loss rates of E-cadherin membranous expression in 
normal tissue and cancer tissue were significant (P < 0.01) and 
the result was not different from the previous result of Almeida 
et al (Almeida et al. 2010).  
We investigated the association between the Cx32 expression 
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and E-cadherin or β-catenin expression (Table 4). In gastric 
normal tissues and cancer tissues, a positive correlation was 
found between the expression and the expression location of 
Cx32 and E-cadherin (Spearman rho = 0.471, P < 0.01). In 
other words, as the Cx32 expression was turning from normal 
membranous expression to cytoplasmic expression and lost 
eventually, the E-cadherin expression was also turning from 
normal membranous expression to cytoplasmic expression and 
then lost eventually. 
Next, we investigated β-catenin, another marker well known 
as a cell adhesion molecule. The immunohistochemical staining 
test showed that it was expressed at the intercellular boundary 
in gastric normal epithelial cells (Fig. 7G). In some tumor 
epithelial cells, the expression at the intercellular boundary was 
decreased whereas cytoplasmic expression was increased (Fig. 
7H). However, in other tumor regions, clustered tumor cells 
only with nuclear expression were found without any 
membranous expression (Fig. 7I). We investigated the location 
of the β-catenin expression in normal tissue and tumor tissue. 
The loss rate of normal membranous expression of β-catenin 
was 4.84% (3/62) in gastric normal tissue, whereas it was 60% 
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(63/105) in gastric cancer tissue. The rate of nuclear 
expression was 0% (0/62) in normal tissue, while it was 35.2% 
(37/105) in tumor tissue. The result was not different with that 
of previous studies (Kim et al. 2011, Jawhari et al. 1997). 
There was a significant difference in the loss rate of 
membranous expression and the rate of nuclear expression 
between gastric normal tissue and tumor tissue (P < 0.05).  
Next, we investigated the correlation in the expression and 
the location of expression between Cx32 and β-catenin and 
the result showed that there was a significant correlation in the 
expression and the location of expression between Cx32 and β
-catenin in gastric normal tissue and tumor tissue (Spearman 
rho = 0.519, P < 0.01) (Table 4). In other words, as the Cx32 
expression was turning from normal membranous expression to 
cytoplasmic expression and lost eventually, the β-catenin 
expression was also turning from the normal membranous 








Figure 7. Immunohistochemistry for adhesion proteins Cx32, E-
cadherin, β-catenin in gastric normal tissues (A, D, and G) and 
cancer tissues (B, C, E, F, H, and I).  
A, Cx32 protein in normal stomach: intercellular expression; B, 
Cx32 protein in moderately differentiated adenocarcinoma: 
intracytoplasmic expression; C, Cx32 protein in poorly 
differentiated adenocarcinoma: negative staining; D, E-cadherin 
protein in normal tissue: strong membranous expression; E, E-
cadherin protein in poorly differentiated adenocarcinoma: 
cytoplasmic and partial membranous expression; F, E-cadherin 
protein in signet ring cell carcinoma: negative staining; G, β-
catenin protein in normal tissue: strong membranous and 
cytoplasmic expression; H, β-catenin protein in poorly 
differentiated adenocarcinoma: loss of membranous expression; 
I, β-catenin protein in signet ring cell carcinoma: nuclear 





Table 4. The expression of Cx32 in relation to that of adhesion 
proteins E-cadherin and β-catenin in human normal gastric 




Membranous Cytoplasmic Loss 
E-cadherin      < 0.01 
Membranous 70 40 26 4  
Cytoplasmic 80 8 48 24  
Loss 17 3 8 6  
β-catenin      < 0.01 
Membranous 101 47 46 8  
Cytoplasmic 29 3 19 7  
Nuclear 37 1 17 19  
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The relationship between cell cycle-regulatory 
proteins and Cx32 expression 
For the next, we examined p21Cip1, and p27Kip1 expressions in 
normal and cancer tissues to investigate the correlation 
between expression of the typical cell cycle-regulatory 
proteins and the Cx32 expression. The immunohistochemical 
staining test showed that p21Cip1 showed nuclear expression in 
both normal tissue (Fig. 8A) and tumor tissue (Fig. 8B and C). 
The p21Cip1 positive cell rate was 100% (62/62) in gastric 
normal tissue, while it was 63.8% (67/105) in tumor tissue. 
The positive cell rate was significantly lower in tumor cell than 
in normal tissue (P < 0.05) and this result was not different 
with that of previous studies (Liu et al. 2001).  
The correlation between p21Cip1 expression and Cx32 
expression as well as the expression location was investigated 
and the result showed a positive correlation (Spearman rho = 
0.475, P < 0.01) (Table 5). As the Cx32 expression was 
turning from normal membranous expression to cytoplasmic 




In most of the normal tissues, p27Kip1 showed nuclear 
expression, but cytoplasmic expression was also found in some 
of them (Fig. 8D). Some tumor cells showed nuclear expression 
(Fig. 8E) or negative staining (Fig. 8F). The p27Kip1 positive 
cell rate was 96.8% (60/62) in normal tissue, while it was 
61.9% (65/105) in tumor tissue, indicating a significant 
difference between normal tissue and tumor tissue (P < 0.01). 
Among the 65 cases in tumor tissue, the expression was high in 
40 cases (38.1%) and low in 25 cases (23.8%). The result was 
not significantly different with that of previous studies (Kim et 
al. 2000).  
The correlation between p27Kip1 expression and Cx32 
expression as well as the expression location was investigated 
and the result showed a positive correlation (Spearman rho = 
0.470, P < 0.01) (Table 5), which indicated that, as the Cx32 
expression was turning from normal membranous expression to 








Figure 8. Immunohistochemistry for p21Cip1, and p27 Kip1 in 
gastric normal tissues (A and D) and cancer tissues (B, C, E, and 
F).  
A, p21Cip1 protein in normal stomach: nuclear expression; B, 
p21Cip1 protein in moderately differentiated adenocarcinoma: 
nuclear expression; C, p21Cip1 protein in poorly differentiated 
adenocarcinoma: negative staining; D, p27Kip1 protein in normal 
tissue: strong nuclear expression; E, p27Kip1 protein in well 
differentiated adenocarcinoma: strong nuclear expression; F, 
p27Kip1 protein in poorly differentiated adenocarcinoma: 




Table 5. The expression of Cx32 in relation to that of cell 







p21Cip1     < 0.01 
  Negative 38 1 16 21  
  Positive 129 50 66 13  
p27Kip1     < 0.01 
Negative 42 3 23 16  
  Low positive 48 9 25 14  
  High positive 77 39 34 4  
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Cell proliferation and cell cycle distribution 
following overexpression of Cx32 in the AGS 
gastric cancer cell line 
Because a negative correlation was found between cell 
proliferation and Cx32 expression in human gastric cancer and 
normal tissues, we performed in vitro experiments to further 
examine the direct relationship between Cx32 expression and 
cell proliferation. The value of BrdU absorbance decreased 
approximately 30-40% in the AGS cells overexpressing Cx32 
compared to that in wild-type AGS cells or AGS cells 
transfected with a control vector (P < 0.05). There was no 
significant difference in the value between wild-type AGS cells 
and AGS cells transfected with a control vector (P > 0.05) (Fig. 
9A). These results suggested that Cx32 overexpression 
inhibits cell proliferation in AGS cells. 
Having demonstrated that Cx32 overexpression negatively 
regulated cell proliferation, we next quantified the cell cycle 
distribution of AGS cells wild-type, AGS cells transfected with 
control vector, and AGS cells transfected with Cx32 vector (Fig 
9B). The percentage of G1-phase cells was significantly 
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greater in AGS cells transfected with Cx32 vector (68.06% ± 
3.93%) than in AGS cells wild-type (40.54% ± 1.80%) or AGS 
cells transfected with control vector (46.91% ± 2.78%) (P < 
0.05). In addition, the percentage of S-phase cells was 
significantly less in AGS cells overexpressing Cx32 (11.32% ± 
0.24%) than in AGS cells wild-type (26.44%±3.04%) or AGS 
cells transfected with control vector (22.13% ± 2.86%) 
(P<0.05). The percentage of cells in G2-M phase did not differ 
among groups (P > 0.05), and there were no significant 
differences in G1- and S-phase populations between AGS cells 
wild-type and AGS cells transfected with control vector (P > 
0.05). These results suggest that Cx32-dependent inhibition of 






Figure 9. Cell proliferation and cell cycle distribution analyses 
showed that Cx32 overexpression inhibited cell proliferation 
through G1 arrest in AGS cells.  
A, Bromodeoxyuridine assay. The bars represent the means ± 
standard deviations of difference of absorbance. Cell 
proliferation was decreased in AGS cells overexpressing Cx32 
compared to the control groups. *P < 0.05; relative to control 
groups. B, cell cycle distribution. The bars represent the means 
± standard deviations of the percentage of cell-cycle stage. 
The percentage of G1-phase cells was significantly greater in 
AGS cells transfected with Cx32 vector (68.06% ± 3.93%) 
than in wild-type AGS cells (40.54% ± 1.80%) or AGS cells 
transfected with control vector (46.91% ± 2.78%)(P < 0.05). 
In addition, the percentage of S-phase cells was significantly 
less in AGS cells overexpressing Cx32 (11.32% ± 0.24%) than 
in wild-type AGS cells (26.44% ± 3.04%) or AGS cells 
transfected with control vector (22.13% ± 2.86%)(P < 0.05). 
*P < 0.05; Vs relative to the control groups in G1-phase. #P < 
0.05; relative to control groups in the S-phase. 
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p21Cip1 and p27Kip1 expression following 
overexpression of Cx32 in the AGS gastric cancer 
cell line  
Because Cx32 overexpression affected the cell-cycle 
distribution, we sought to determine whether the expression of 
cell-cycle regulatory proteins differed among the three groups, 
focusing on changes in p21Cip1 and p27 Kip1 (Fig. 10). Stable cell 
lines were screened for the amount of Cx32 protein by 
immunoblotting. Western blot analyses revealed that Cx32 
expression in AGS cells transfected with Cx32 vector was 
approximately 2- to 3-fold greater compared to wild-type 
AGS cells or AGS cells transfected with control vector. The 
expression of p21Cip1 at the mRNA level increased 2- to 2.5-
fold and the expression of p21Cip1 protein was approximately 
30-50% greater in AGS cells overexpressing Cx32 compared 
to that of wild-type AGS cells and AGS cells transfected with 
control vector (P < 0.05). p27Kip1 expression at the mRNA level 
increased 60-90% and the content of p27Kip1 protein was also 
approximately 2- to 3-fold greater in AGS cells 
overexpressing Cx32 than the control cell lines (P < 0.05). The 
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levels of all proteins in wild-type AGS cells and AGS cells 
transfected with control vector were not significantly different 
(P > 0.05). Our results thus show that Cx32 overexpression in 
AGS cells induced an increase in p21Cip1 and p27Kip1 







Figure 10. Real-time RT-PCR and Western blotting analyses 
showed that Cx32 overexpression increased the expression of 
p21Cip1 and p27Kip1 at mRNA and protein levels in AGS cells.  
A, The bars represent the means ± standard deviations of ratio 
of p21Cip1 and p27Kip1/β-actin in the real-time RT-PCR data. 
Expression of p21Cip1 and p27Kip1 was significantly higher than 
control groups; B, Cx32, p21Cip1, and p27Kip1 protein levels were 
analyzed by Western blotting using β-actin as the loading 
control; C, The density graph indicates the ratios of Cx32, 
p21Cip1 and p27Kip1/β-actin in the Western blot data. 
Expression of Cx32, p21Cip1, and p27Kip1 was significantly higher 





Similar to other previous studies, we recently found that Cx32 
expression is often shifted from an intercellular to an 
intracytoplasmic location, or is even lost, in human gastric 
cancer (Jee et al. 2011). Although altered expression of Cxs 
has been reported in various malignant tumors, including gastric 
cancer, the exact role of Cx32 in gastric carcinogenesis has not 
yet been clearly defined. Because tumor growth reflects an 
imbalance between cell proliferation and apoptosis, we 
investigated whether altered Cx32 expression might impact 
gastric cancer development, placing special emphasis on 
disruption of normal cell proliferation. 
Recent studies showed that Cxs and adhesion proteins 
cadherins and catenins play important roles in carcinogenesis 
and their expressions were investigated in many tumors. 
However, there are only a few publications on Cxs and 
cadherins or catenins (Jinn et al. 1998, Xu et al. 2008) and it is 
still unclear that whether Cx32 and adhesion proteins affect 
each other or not in gastric carcinogenesis. Thus, we have 
investigated relationship between Cx32 and E-cadherin or β-
catenin using immunohistochemistry. In this study, we showed 
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statistically significant positive correlations between E-
cadherin or β-catenin expression and Cx32 expression. 
Immunohistochemical analyses of Cxs and adhesion molecules 
in endometriod adenocarcinomas and of Cx43 and E-cadherin 
in gastric cancer were similar to our results (Wincewicz et al. 
2010, Tang et al. 2010). Thus, Cxs and adhesion proteins 
expression correlated with each other and concurrent reduction 
or loss and/or aberrant intracellular localization of two proteins 
may contribute to the gastric carcinogenesis. These alterations 
may be one of the key mechanisms through which changes 
toward dedifferentiation and progression of gastric cancers are 
mediated. 
Furthermore, we confirmed that overexpression of Cx32 
restored the level of E-cadherin and β-catenin. This result 
indicates that potential connections exist between Cx32 and E-
cadherin or β-catenin in gastric epithelial cells. Murine skin 
papilloma cells that are transfected with E-cadherin showed 
Cx43 translocation from cytoplasm to cell-cell contact 
membranes owing to actin filaments (Hernandez-Blazquez et al. 
2001). It means that E-cadherin is instrumental in regulating 
intracellular trafficking of Cx43. And the intracellular loop of 
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the Cx43 protein chain interacts with cadherins (Nambara, 
Kawasaki and Yamasaki 2007) and Cx43 is a target of Wnt 
signaling and β-catenin (van der Heyden et al. 1998). Another 
experiment in mouse epidermal cells showed that cells with E-
cadherin transfection expressed GJIC in calcium-dependent 
manner and it suggests that calcium-dependent regulation of 
GJIC is directly controlled by a calcium-dependent cell 
adhesion molecule, E-cadherin (Jongen et al. 1991). These 
studies suggest that abnormal expression of E-cadherin or ß-
catenin may affect Cx expression and localization and that GJIC 
mediated via them might be involved in gastric carcinogenesis. 
Because individual Cxs differ in function and expression and 
correlation between Cx32 and adhesion proteins has not yet 
been clearly defined, additional studies will be needed to 
confirm the role of Cx32 in gastric carcinogenesis. Future 
studies, including functional and site-directed mutagenesis, 
should reveal whether these interactions are direct or reflect 
precipitation of macromolecular/subcellular complexes. 
The involvement of Cxs in the regulation of tumor cell 
proliferation has been suggested by a number of recent studies. 
A study to knock down Cx32 expression in rat hepatoma cells 
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has shown that the magnitude of cell proliferation is inversely 
proportional to the level of Cx32 expression (Edwards et al. 
2008). Furthermore, the incidence of hepatic and pulmonary 
neoplasms was found to be higher in Cx32-deficient and 
Cx43-deficient mice, respectively, than in their wild types 
littermates (Avanzo et al. 2006, Temme et al. 1997). An 
immunohistochemical analysis of H. pylori-associated mouse 
gastric tumors showed an inverse relationship between Cx32 
and Ki67 expression (Jee et al. 2011). Our in vitro Cx32 
overexpression study is in full agreement with these studies. 
Cx expression per se can reduce the proliferation of cancer 
cells, an effect that is independent of localization to the plasma 
membrane and formation of gap-junction plaques by 
transfected Cxs (Huang et al. 1998). Other studies reinforce 
this interpretation, showing that some Cx mutants that are 
incapable of plasma membrane insertion are nonetheless 
capable of down-regulating the cell proliferation (Krutovskikh 
et al. 2000, Olbina and Eckhart 2003). In canine mammary 
tumors, malignant tumors showed increased cytoplasmic 
staining for both Cx26 and Cx43, whereas hyperplastic and 
benign neoplastic glands showed only membranous expression. 
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Moreover, the expression and distribution of Cx26 and Cx43 
were inversely correlated to cell proliferation in malignant 
tumors (Torres et al. 2005). Consistent with these 
observations, we found a relationship between Cx32 localization 
and cell proliferation in our tissue microarray-based 
immunohistochemical study. Thus, Cxs clearly play some role 
in proliferative aspects of gastric cancer development but 
further studies are need to decipher how actually or what 
pathways are involved. Depending upon such mechanisms, Cxs 
might be good target for cancer therapy. 
Our investigation of the Cx32 effect on the cell cycle showed 
that Cx32 inhibits cell cycle progression. Similarly, 
overexpression of Cx43 has been shown to suppress the 
proliferation of human osteosarcoma U2OS cells through 
inhibition of cell cycle transition from G1- to S-phase (Zhang 
et al. 2001). In addition, the forced expression of Cx43 and 
Cx32 was reported to decrease the growth of neoplastic mouse 
lung and rat liver epithelial cells in vitro in association with a 
reduction in exit of cells from G1-phase (Koffler et al. 2000). 
These data suggest that Cx32 regulates cell proliferation, at 
least in part, through G1-phase arrest. We then investigated the 
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expression levels of p21Cip1 and p27Kip1 following Cx32 in AGS 
cells. We found that the degrees of p21Cip1 and p27Kip1 
expression were significantly increased both at the mRNA and 
protein levels. In rat glioma cells, tolbutamide was shown to 
increase Cx43 protein synthesis, an effect that was 
accompanied by up-regulation of p21Cip1 and p27Kip1 (Sanchez-
Alvarez et al. 2006). As shown in Zhang et al., increased 
synthesis as well as post-transcriptional reduced degradation 
of p27Kip1 was evident in human osteosarcoma cell line U2OS 
(Zhang et al. 2001). Cx43 overexpression can inhibit cell 
proliferation in association with a decrease in the stability of S-
phase kinase-associated protein 2 (Skp-2), which is involved 
in cell-cycle regulation. This study raises another intriguing 
possibility that Cxs might have other roles, such as the direct 
transcriptional regulation of various genes that might include 
p21Cip1 and p27Kip1 (Giepmans 2004). The regulation mechanism 
of Cxs in p21Cip1 and p27Kip1 expression might vary according to 
tumor type and Cx isoform. Hence, additional studies are 
needed for better understanding of p21Cip1 and p27Kip1 
expression mechanisms by Cxs in gastric cancer. 
In conclusion, our immunohistochemical analysis of patient-
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matched normal and cancerous gastric tissues demonstrated an 
inverse relationship between Cx32 expression and proliferation, 
and our in vitro study of the effects of Cx32 overexpression 
showed that Cx32 inhibited the proliferation of gastric cancer 




GENERAL DISCUSSION AND CONCLUSION 
To explore the role of Cx32 in gastric carcinogenesis, we 
investigated altered expression and localization of Cx32 in 
human gastric cancer using a tissue array-based approach, H. 
pylori-induced murine gastric tumors, and preneoplastic 
changes (mucous metaplasia) in murine gastric tissues. We 
examined the relationship between expression of Cx32 and cell 
proliferation marker Ki67 or cell-cycle regulatory proteins 
p21Cip1 or p27Kip1 using immunohistochemistry. In addition, we 
evaluated the relationship between E-cadherin or β-catenin 
expression and Cx32 expression. In addition, we examined cell 
proliferation, cell cycle distribution, and change of levels of the 
cell-cycle regulatory proteins p21Cip1 and p27Kip1 following 
Cx32 overexpression in the human gastric cancer cell line AGS.  
In immunohistochemical analyses, the frequency of Cx32 loss 
of expression was significantly higher in human 
adenocarcinomas than in normal stomach. As tumor cells were 
less differentiated, Cx32 expression levels and intercellular and 
intracytoplasmic staining were also significantly lower. In 
normal stomach, Cx32 expression in foveolar surface cells in 
the gastric pit was strong, whereas that in basal cells was weak. 
118 
 
Deep pyloric glandular cells showed punctuate Cx32 staining in 
the membranes and/or cytoplasm. In tumor cells this 
intercellular expression was lost, and Cx32 expression varied 
according to the differentiation status of tumor cells. Some 
adenocarcinomas showed mild to moderate Cx32 expression in 
the cytoplasm, whereas others showed loss of staining in the 
cell membrane and weak positive staining as intracytoplasmic 
dots or negative staining. As human gastric tumors progressed 
to more undifferentiated stages, the intercellular and 
intracytoplasmic expression and intensity of Cx32 decreased 
significantly and was eventually lost. In mucous metaplasia of 
the mouse stomach that is meant to be pre-neoplastic lesions, 
Cx32 was mainly expressed in the cytoplasm of epithelial cells. 
Similar to these results, immunohistochemical analysis of Cx 
expression in hepatocellular carcinoma and colorectal 
carcinoma showed the presence of Cx protein in the form of 
dots in both cell membrane and cytoplasm (Nakashima et al. 
2004, Kanczuga-Koda et al. 2005a). These results are 
consistent with the idea that altered expression of Cx32 plays 
an important role in the transformation of glandular epithelial 
cells and progression of gastric cancers. 
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Because tumor growth reflects an imbalance between cell 
proliferation and apoptosis, we investigated whether altered 
Cx32 expression might impact gastric cancer development, 
placing special emphasis on disruption of normal cell 
proliferation. An examination of Ki67-positivity in relation to 
the pattern of Cx32 expression in human and murine gastric 
tissue showed that the frequency of Ki67-positive cells 
increased as Cx32 localization shifted from a membranous to 
cytoplasmic pattern and was further increased with loss of 
expression. Our demonstration that Cx32 expression was low in 
Ki67-positive cells is consistent with the previous 
demonstration of a possible inverse relationship between Cx43 
expression and cell proliferation in canine bone tumors 
(Sanches et al. 2009). Taken together, the inverse relationship 
between proliferation and Cx expression suggests that Cx32 
expression might be an indicator of carcinogenesis potential, 
and as such may serve as an additional cancer biomarker. 
We then investigated the correlation between expression of 
the typical cell-cycle regulatory proteins p21Cip1 or p27Kip1 and 
that of Cx32. As the Cx32 expression changed from normal 
membranous expression to cytoplasmic expression or was lost, 
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the p21Cip1- and p27Kip1-positive cell rate decreased (negative 
staining). Thus, Cx32 expression and expression pattern are 
associated with not only cell proliferation but also cell-cycle 
regulatory proteins. 
We have also investigated the relationship between Cx32 and 
E-cadherin or β-catenin, using immunohistochemistry. In this 
study, we showed statistically significant positive correlations 
between E-cadherin or β-catenin expression and Cx32 
expression. As Cx32 expression was turning from normal 
membranous expression to cytoplasmic expression and was 
eventually lost, the E-cadherin expression also changed from 
the normal membranous expression to cytoplasmic expression 
and was eventually lost. And as Cx32 expression changed, the 
β-catenin expression was also turning from the normal 
membranous expression to cytoplasmic expression or nuclear 
expression. Immunohistochemical analyses of Cxs and adhesion 
molecules in endometriod adenocarcinomas and of Cx43 and E-
cadherin in gastric cancer showed similar results to ours (Tang 
et al. 2010, Wincewicz et al. 2010). Thus, Cxs and adhesion 
protein expression correlated with each other, and concurrent 
reduction or loss and/or aberrant intracellular localization of 
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two proteins may contribute to gastric carcinogenesis. These 
alterations may be one of the key mechanisms through which 
changes toward dedifferentiation and progression of gastric 
cancers are mediated. 
To further examine the direct relationship between Cx32 
expression and cell proliferation, gastric cancer cell line AGS 
cells were transfected with a Cx32 expression plasmid or 
control vector. Cell proliferation was decreased in AGS cells 
overexpressing Cx32 compared to wild-type AGS cells or AGS 
cells transfected with control vector. The percentage of G1-
phase cells was significantly greater and that of S-phase was 
less in AGS cells overexpressing Cx32 vector than in wild-
type AGS cells or AGS cells transfected with control vector. 
Real-time RT-PCR and Western blot analyses revealed p21Cip1 
and p27Kip1 levels were greater in AGS cells overexpressing 
Cx32 vector compared to control groups. The involvement of 
Cxs in the regulation of tumor cell proliferation has been 
suggested by a number of recent studies. Studies using RNAi to 
knock down Cx32 expression in rat hepatoma MH1C1 cells have 
shown that the magnitude of cell proliferation is inversely 
proportional to the level of Cx32 expression (Edwards et al. 
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2008). Similarly, overexpression of Cx43 has been shown to 
suppress the proliferation of human osteosarcoma U2OS cells 
through inhibition of cell-cycle transition from G1- to S-phase 
(Zhang et al. 2001). As shown in Zhang et al., increased 
synthesis as well as post-transcriptional reduced degradation 
of p27Kip1 was evident in human osteosarcoma cell line U2OS 
(Zhang et al. 2001). These data suggest that Cx32 plays some 
roles in gastric cancer development by inhibiting gastric cancer 
cell proliferation through cell cycle arrest and cell cycle 
regulatory proteins. 
In conclusion, our immunohistochemical analysis 
demonstrated that that the altered Cx32 expression, specifically 
the loss of Cx32 expression and the gain of intracytoplasmic 
Cx32, was observed not only in adenocarcinoma and adenoma 
but also in mucous metaplasia. In addition we found a 
correlation between Cx32 expression pattern and cell 
proliferation. Our in vitro study of the effects of Cx32 
overexpression showed that Cx32 inhibited the proliferation of 
gastric cancer cells through cell cycle arrest and upregulation 
of p21Cip1 and p27Kip1. Together, these results suggest that 
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 생 과   포  증식에  
있어  connexin32  역할 
 
지 향 
학과 병리학 공 
울 학  학원 
 
 한 포  인 하는 포 사이에는 포막  통하는 포 간 
channel이 존재하며, 이는 포 간 신 달  담당한다. Glucose  
glutamate, adenosine trisphosphate (ATP), 이  같  질  산
 통해 포  장과 분 , 항상  지한다. 이 channel  각각  
포막에 있는 connexon이라는 단 질 입자가 결합하여 
며, 이 connexon  6개  connexin (Cx)  구 어 있다. 각각  
connexin  분자량에 라 이름이 지어 며, 능과  양상이 각
 다르다. 이 포 간 신 달  이상  질병과 매우 한 이 
있 며, 특히 포 간 신 달이 해  경우  생  한다.  
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본 논   생에 있어 포 간 신 달  구  요소인 Cx32
 역할   해, 사람  조직과 Helicobacter pylori 감염에 
한 마우스 모델에   조직과  병변에  이 단 질  
과   조사하 다. 그리고 Cx32  포 증식과  계를 
 해, 포 증식 인자인 Ki67 또는 포주  조  단 질인 p21Cip1 
또는 p27Kip1  과 Cx32   계를 조사하 며, 포부
착단 질 E-cadherin과 β-catenin   과 Cx32   
계도 조사하 다. 그리고  포주 AGS 포에 Cx32 cDNA를 
주입하여 포 증식과 포 주  분포, 포주  조  단 질 p21Cip1
과 p27Kip1   도를 조군과 하 다. 
면역조직 학검사에  사람과 마우스  조직과 상 조직에  
Cx32 소실  한 결과 Cx32 소실  상조직에 해 조
직에   있게 높 며, 분 도에 라 분 한 뒤 소실  조사
한 결과 분 도가 낮  소실   있게 증가하 다. Cx32
는 주  상  소  포  막에  강하게 었 며 ( 포 사이 
),  포에 는 포막과 포질에  Cx32  이 찰
었다. 종양에  Cx32는 상과 하여 변   보 며, 
분 도에 라 다양하게 었다. 일부 종양 상피 포에 는 포
질에  었 며, 일부 종양 포에 는  지 다. 
  병변인 막 생  보인 상피 포에 는 주  포질 
이 찰 었다. Cx32 과   Ki67 양 과  계를 
153 
 
본 결과, 사람과 마우스 조직 모 에  Cx32 이 포막 
에  포질 ,  소실  진행  Ki67 양  증가
하 다. 그리고 Cx32  과 p21Cip1 또는 p27Kip1 양  계
를 조사한 결과, Cx32 이 포막 에  포질 , 
지  p21Cip1과 p27Kip1  양  감소하 다. 또한 Cx32 
 과 포 부착 단 질 E-cadherin    계는 Cx32 
이 포막 에  포질 , 지  E-
cadherin도 포막 에  포질 ,  소실  변
었다. 그리고 다른 잘 진 포 부착 단 질 β-catenin  경우, 
Cx32  계는 Cx32 이 소실  β-catenin는 포막 
에  포질 , 핵 내 이 찰 었다. 다  포
주 AGS 포를 이용하여 Cx32  역할  보 다. Cx32 cDNA가 
주입  AGS 포는 조군과 하여 포  증식이  있게 억
었 며, G1  이 높 며 S   감소 어 포 주  분
포에 도 향  주었다. Real-time 역 사 합효소 연쇄  
(reverse transcription polymerase chain reaction)과 Western 
blot 검사를 실시하여, p21Cip1과 p27Kip1    검사한 결과 
Cx32 cDNA가 주입  AGS 포는 조군과 하여 p21Cip1과 
p27Kip1  증가하 다. 
면역조직 학검사 결과를 탕  Cx32  변  , 즉, 포
질에   또는 소실  과  병변에  찰 었다. 그리고 
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Cx32 과 변 는 포 증식과 이 있 며, 포주 
AGS 포를 이용한 생체 외 실험에 도 Cx32는 포 주  분포를 변
시키고 p21Cip1과 p27Kip1  증가시  포 증식에 향  주었
다. 이  같  결과를 탕  Cx32는  에 요한 역할  한
다고 생각 다. 
 
주요어 : connexin32, , 포증식, 포 간 신 달, , AGS cell 






 병리학이라는 과목이 좋  심  열   학  과
 시작하 지만 엇 하나 만만한 것이 없었습니다. 하지만 이러한 과
 통해 학  과뿐만 니라 인생  살 가는 요한 가르침도 
얻었습니다. 이 소고를 하 지 많  분들  도움이 있어 이  
통해 감사  마  하고자 합니다. 
 미 한 를 가르쳐 주시고  이끌어 주신 용 
님께 진심  감사드립니다. 귀한 시간  내어 를 인식하는 법
과 논 작  등  지도해 주신 남 택 님께도 이 감사드립니다. 
항상 스한 심  주셨  희  님과 경 님, 신 
에 논  심사를 맡  주시고 심하게 지도해 주신 양규 님, 
학원 생 뿐만 니라 인생에 한 조언도 해주신 창 님 감
사드립니다. 이러한 님들  가르침이 에게는 소 한 거름이 
었습니다. 
 연구  병리학 공부에 많  도움  주신 , 민  효
언니, 연구실에  같이 진단 공부하고 연구 주 에 해 토 한 Bidur, 
일  미 , 진, 든든한 후  원이  보람, , 민, 하
 함께 했  시간과 추억들  는 잊   없  것 같습니다. 실험에 
많  도움   경희에게도 고마운 마  합니다. 
지  를 존재하게 해주신 부모님, 큰 이 강인하지 못하다고 항
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상 타 워 하시는  청주  울   마다하시지 고 뒷 라
지하느라 쓰신 엄마, 공부하느라 맏며느리 역할도  못하는 
게 맡  를 열심히 하는 것이 효도  일부라고 격 해주신 어 님과 
버님께는 감사  마 보다는 죄송한 마 이 니다. 조용히 사랑
 원해주신 할 니  외할 니께는 항상 건강하시 를 라며 감
사  인사를 드립니다. 가 힘들어할 마다 원  해  구 같  
내 동생 연, 등학 부  인연 지 , 17  지  구들 지 , 진
원, 연 이는 나 큰 힘이 었습니다. 낯  경에  공부하느라 
힘들지만 도리어 게 큰 용  한한 신뢰를   자 장 필
님과 이 결실  함께 나 고 싶습니다.  
돌이 보니 그 동  나 많  분들에게 심과 사랑  습니
다. 다시 한 번 진심  감사드립니다.  몸과 마 가짐  새롭
게 다지고, 스스  역량  키워 사회에 조 이나마 여하도  하겠습
니다. 
 
